# EDGAR Filing Document

**Accession Number:** 0001211805
**File Stem:** 0001493152-25-013135
**Filing Date:** 2025-9
**Character Count:** 237693
**Document Hash:** fe2488177af8d7ba8cd2e1de770f05af
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-013135.hdr.sgml**: 20250912

**ACCESSION NUMBER**: 0001493152-25-013135

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 18

**CONFORMED PERIOD OF REPORT**: 20250908

**ITEM INFORMATION**: Entry into a Material Definitive Agreement

**ITEM INFORMATION**: Completion of Acquisition or Disposition of Assets

**ITEM INFORMATION**: Unregistered Sales of Equity Securities

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250912

**DATE AS OF CHANGE**: 20250912

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** My Size, Inc.
- **CENTRAL INDEX KEY:** 0001211805
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-PREPACKAGED SOFTWARE [7372]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37370
- **FILM NUMBER:** 251310087

**BUSINESS ADDRESS:**
- **STREET 1:** 4 HANEGEV ST,
- **STREET 2:** POB 1026,
- **CITY:** AIRPORT CITY
- **STATE:** L3
- **ZIP:** 7010000
- **BUSINESS PHONE:** 972-36009030

**MAIL ADDRESS:**
- **STREET 1:** 4 HANEGEV ST,
- **STREET 2:** POB 1026,
- **CITY:** AIRPORT CITY
- **STATE:** L3
- **ZIP:** 7010000

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Mysize Inc.
- **DATE OF NAME CHANGE:** 20150317

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** TOPSPIN MEDICAL INC
- **DATE OF NAME CHANGE:** 20021226

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): September 8, 2025**

**MY SIZE, INC.**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-37370** | **51-0394637** |
| (State or other jurisdiction<br> of incorporation) | (Commission<br> File Number) | (IRS Employer<br> Identification No.) |

---

**4 HaNegev, POB 1026**

**Airport City, Israel 7010000**

(Address of principal executive offices and Zip Code)

Registrant's telephone number, including area code **+972-3-600-9030**

**N/A**

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, $0.001 par value per share | MYSZ | Nasdaq Capital Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 1.01** **Entry into a Material Definitive Agreement.**

The information contained in Item 2.01 is hereby incorporated herein by reference.

**Item 2.01** **Completion of Acquisition or Disposition of Assets.**

On September 8, 2025, My Size Inc., a Delaware corporation (the "Company") entered into a Share Sale and Purchase Agreement (the "Purchase Agreement") with certain sellers (the "Sellers"), who are the holders of 100% of the share capital of ShoeSize.Me AG, a Swiss company (the "Target"), pursuant to which the Sellers agreed to sell to the Company all of the issued and outstanding shares of Target (the "Transaction"). The Transaction closed on the same day (the "Closing Date").

In consideration for the purchase of the shares of Target and in accordance with the Purchase Agreement, the Sellers received (i) a cash payment of $150,000 and (ii) 241,093 shares of the Company's common stock (the "Shares") having an aggregate value of $290,000 (the "Equity Consideration"), determined by dividing $290,000 by the average closing price of the Company's common stock during the seven trading days immediately preceding the Closing Date.

In addition, pursuant to the Purchase Agreement, the Company issued to a key employee of Target a warrant (the "Warrant") to purchase up to 28,000 Shares (such Shares underlying the Warrant, the "Warrant Shares"). The Warrant provides for a tiered exercise structure, with (i) 10,000 Warrant Shares exercisable at $2.00 per Warrant Share, (ii) 6,000 Warrant Shares exercisable at $3.00 per Warrant Share, (iii) 5,000 Warrant Shares exercisable at $4.00 per Warrant Share, (iv) 4,000 Warrant Shares exercisable at $5.00 per Warrant Share, and (v) 3,000 Warrant Shares exercisable at $6.00 per Warrant Share.

The Warrant is subject to vesting upon satisfaction of certain service-based, financial performance and integration milestones, as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● <u>Continuing Service Milestone</u>: 50% of the Warrant shall vest and become exercisable on the 12-month anniversary of the issuance date of the Warrant, provided that the Warrant holder shall have been continuously providing services to the Company through such 12-month anniversary.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● <u>Financial Result Milestone</u>: The vesting of up to 25% of the Warrant is contingent on the Target's gross revenue for the 12-month period following the closing date (beginning September 1, 2025) compared to the 12-month period ended August 31, 2025 (the prior-year revenue) as follows: (i) the entire 25% of the Warrant shall vest and become exercisable if the Target's post-closing revenue is equal to or greater than 95% of the prior-year revenue, (ii) 12.5% of the Warrant (or 50% of the portion the Warrant subject to the vesting terms in connection with Financial Result Milestone) shall vest and become exercisable if the Target's post-closing revenue is equal to or greater than 80% but less than 95% of the prior-year revenue; and (iii) no portion of the Warrant subject to the vesting terms in connection with Financial Result Milestone shall vest if the Target's post-closing revenue is less than 80% of the prior-year revenue.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● <u>Integration Milestone</u>: The vesting of 25% of the Warrant is contingent on the completion of the full integration (as determined by the Company at its reasonable discretion) of the Target into the Company's wholly-owned subsidiary, Naiz Bespoke Technologies, S.L., by March 31, 2026.

In connection with the Purchase Agreement, certain Sellers (the "Major Shareholders") entered into (i) a voting agreement (the "Voting Agreement") with the Company, as further described below, and (ii) customary six-month lock up agreements (the "Lock-Up Agreement") with the Company.

The Voting Agreement provides that the voting of any Shares held by the Major Shareholders will be exercised exclusively by a proxy designated by the Company's board of directors from time to time (the "Proxy") and that each Major Shareholder will irrevocably designate and appoint the then-current Proxy as its sole and exclusive attorney-in-fact and proxy to vote and exercise all voting right with respect to the Shares held by each Major Shareholder. The Voting Agreement also provides that, if the voting power held by the Proxy, taking into account the proxies granted by the Major Shareholders and the Shares owned by the Proxy, represents 20% or more of the voting power of the Company's stockholders that will vote on an item (the "Voting Power"), then the Proxy shall vote such number of Shares in excess of 19.9% of the Voting Power in the same proportion as the Shares that are voted by the Company's other stockholders. The Voting Agreement will terminate on the earliest to occur of (i) such time that such Major Shareholder no longer owns any shares of the Company's common stock, (ii) the sale of all or substantially all of the assets of the Company or the consolidation or merger of the Company with or into any other business entity pursuant to which stockholders of the Company prior to such consolidation or merger hold less than 50% of the voting equity of the surviving or resulting entity, (iii) the liquidation, dissolution or winding up of the business operations of the Company, and (iv) the filing or consent to filing of any bankruptcy, insolvency or reorganization case or proceeding involving the Company or otherwise seeking any relief under any laws relating to relief from debts or protection of debtors.

The Purchase Agreement and Voting Agreement contain customary representations, warranties, indemnification and other provisions customary for transactions of this nature. In addition, the Major Shareholders will be subject to non-competition and non-solicitation provisions pursuant to which they agree not to engage in competitive activities with respect to the Company's business.

The Purchase Agreement, the Warrant, the Voting Agreement and the Lock-Up Agreement are referred to herein as the "Transaction Documents." The foregoing descriptions of the Transaction Documents do not purport to be complete and are qualified in their entirety by reference to the full text of such agreements, copies of which are filed as exhibits to this Current Report on Form 8-K and are incorporated by reference herein.

**Item 3.02.** **Unregistered Sales of Equity Securities.**

The information contained in Item 2.01 is hereby incorporated herein by reference. The issuance of the Equity Consideration is exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"), pursuant to an exemption provided by Regulation S thereof as an off-shore transaction with non-U.S. persons.

**Item 7.01.** **Regulation FD Disclosure.**

On September 11, 2025, the Company issued a press release announcing the acquisition of Target. A copy of the press release is attached hereto as Exhibit 99.1.

The press release and the information set forth therein shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise be subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act or the Exchange Act.

**Item 9.01** **Financial Statements and Exhibits.**

(a) Financial
 Statements of Business Acquired. If required, the Company intends to file financial statements required by this Item 9.01(a) under
 the cover of an amendment to this Current Report on Form 8-K no later than seventy-one (71) calendar days after the date on which
 this Form 8-K was required to be filed.

(b) Pro
 Forma Financial Information. If required, the Company intends to file the pro forma financial information that is required by this
 Item 9.01(b) under the cover of an amendment to this Current Report on Form 8-K no later than seventy-one (71) calendar days after
 the date on which this Form 8-K was required to be filed.

(c) Not
 applicable.

(d) Exhibits

---

| | |
|:---|:---|
| 10.1<sup>(1)(2)</sup> | [Share Sale and Purchase Agreement, dated as of September 8, 2025, by and among My Size, Inc., Mr. Timo Steitz, Mr. Wilhelm Steitz, Mr. Ettore Weilenmann and the natural and legal persons indicated in Annex 0 thereto.](ex10-1.htm) |
| 10.2<sup>(2)</sup> | [Lock-Up Agreement, entered into on September 8, 2025, by and among My Size, Inc. and the stockholders identified on the signature page thereto.](ex10-2.htm) |
| 10.3<sup>(2)</sup> | [Voting Agreement, dated as of September 8, 2025, by and among My Size, Inc. and the stockholders identified on the signature page thereto.](ex10-3.htm) |
| 10.4 | [Form of Warrant issued by My Size, Inc.](ex10-4.htm) |
| 99.1 | [Press release dated September 11, 2025.](ex99-1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

<sup>(1)</sup> Certain of the exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Registrant agrees to furnish a copy of all omitted exhibits and schedules to the SEC upon its request.

<sup>(2)</sup> Portions of this exhibit (indicated by asterisks) have been omitted under rules of the SEC permitting the confidential treatment of select information. The Registrant agrees to furnish a copy of all omitted information to the SEC upon its request

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **MY SIZE, INC.** | **MY SIZE, INC.** |
| Date: September 12, 2025 | By: | */s/ Ronen Luzon* |
|  | Name: | Ronen Luzon |
|  | Title: | Chief Executive Officer |

---

## Exhibit 10.1

**Exhibit 10.1**

 **Certain confidential information contained in this document, marked by brackets and asterisk ([\*\*\*]), has been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K, because the Company customarily and actually treats such information as private or confidential and the omitted information is not material.**

**SHARE SALE AND PURCHASE AGREEMENT**

**OF THE COMPANY**

**SHOESIZE.ME AG**

**Dated September 8, 2025**

September 8, 2025 (the date of this Agreement).

**PARTIES**

On the one hand,

---

| |
|:---|
| **Mr. Timo Steitz**, of legal age, of German nationality, with address for these purposes in [\*\*\*], and holder of I.D. number [\*\*\*], in force. In his own name and on his own behalf. |
| **Mr. Wilhelm Steitz**, of legal age, of German nationality, with address for these purposes in [\*\*\*], and holder of I.D. number [\*\*\*], in force. In his own name and on his own behalf. |
| **Mr. Ettore Weilenmann**, of legal age, of Swiss nationality, with address for these purposes in [\*\*\*], and holder of I.D. number [\*\*\*], in force (the ***Majority Seller 3***). In his own name and on his own behalf. |

---

Hereinafter, Mr. Timo Steitz, Mr. Wilhelm Steitz and Mr. Ettore Weilenmann shall be jointly referred to as the ***Majority Sellers*** and, any of them, individually and where appropriate as a ***Majority Seller***.

The natural and legal persons indicated in **Annex 0,** with their corresponding identification details and acting in the representation specified therein.

Hereinafter, the Majority Sellers and the natural and legal persons indicated in Annex 0 shall be jointly referred to as the ***Sellers*** and, any of them, individually and where appropriate as a ***Seller***.

On the other hand,

**MY SIZE INC.** company duly constituted under the laws of Delaware (United States), with registered address at HaNegev 4, POB 1026, Airport City, Israel, 701000, and registered within the Commercial Register of Delaware under number 510394637 (the ***Purchaser***).

The Purchaser is duly represented herein by Mr. Ronen Luzon, of legal age, of Israeli nationality, with the same address for these purposes as the one indicated for the represented party, and holder of Israeli passport number 39013432, in his capacity as Chief Executive Officer of the Purchaser.

Hereinafter, the Sellers and the Purchaser shall be jointly referred to as the ***Parties*** and, any of them, individually and where appropriate as a ***Party***.

**EXHIBITIONS**

I. Whereas,
 on the Closing Date, the Sellers are the owners, with all their rights and free of charges and encumbrances and of any other rights
 in favor of third parties, of 253,948 fully paid-in registered shares with a nominal value of CHF 1 each (the  ***Shares***),
 representing one hundred percent (100%) of the share capital and voting rights of **ShoeSize.Me AG**, a corporation (*Aktiengesellschaft*)
 duly constituted under the laws of Switzerland, with registered office at Leberngasse 19, 4600 Olten, Switzerland, and registered
 within the Commercial Register of the canton of Solothurn under number CHE- 177.225.994 (the  ***Company***).

---

| | |
|:---|:---|
|  | On the Closing Date, the Sellers are the owners of the Shares in the proportion and on the basis of the ownership titles set forth in **Annex I**. |
| II. | Whereas, the main activity of the Company is the development of an AI-driven sizing assistant designed to simplify and optimize shoe purchases online by helping customers find the right fit and helping e-tailers sell more efficiently (the ***Activity***). |
| III. | Whereas, the Purchaser has conducted a review of the legal, financial and technical aspects of the Company which was completed on May 18, 2025 (the ***Due Diligence Process***). |
| IV. | Whereas, following the Due Diligence Process, the Purchaser is interested in acquiring and purchasing the Shares, which the Sellers are interested an in position of selling and transferring, subject to the terms and conditions set forth herein. |
| V. | Whereas, in accordance with the foregoing, the Parties agree to enter into this **SHARE SALE AND PURCHASE AGREEMENT** (the ***Agreement***), which shall be governed by the following, |

---

**CLAUSES**

**1.** **DEFINITIONS AND RULES OF INTERPRETATION** 

1.1. For
 the purposes of the Agreement, the terms set out in **Annex 1.1** shall be construed in accordance with their definitions. Other
 terms may be defined elsewhere throughout the Agreement and shall be construed in accordance with the definitions set forth therein.

1.2. The
 Agreement shall be interpreted in accordance with the rules of interpretation set out in **Annex 1.2**.

**2.** **OBJECT AND PURPOSE – SALE AND PURCHASE OF THE SHARES** 

2.1. Subject
 to the performance on the Closing Date of all the actions set out in clause 4 below, each Seller hereby agrees to sell and, at the
 Closing Date, to transfer and assign to the Purchaser, who hereby agrees to purchase and acquire from each Seller, the Shares, free
 and clear of all Liens and encumbrances and with all rights, for the price and on the terms and conditions set out in the Agreement.

2.2. By
 acquiring the Shares, the Purchaser acquires control over the Company's Activity, and over all the properties and rights comprising
 the Company's assets. The transfer of the Shares' ownership and the consequent access to the control of the Company described
 in this clause constitute the ultimate cause and purpose of the Agreement.

**3.** **CONSIDERATION AND PAYMENT** 

3.1. As
 consideration for the Shares, the Purchaser will pay to the Sellers the Initial Consideration, under the terms and conditions set
 forth in this clause 3.

3.2. The
 Initial Consideration has been calculated in accordance with the methodologies agreed by the Parties, who declare and represent to
 be in full agreement with the same.

3.3. <u>Initial Consideration</u> 

3.3.1. On
 the Closing Date, as consideration for their Shares, the Purchaser settles the following consideration: USD 440,000 (the  ***Initial Consideration***), in the form specified below.

---

| | |
|:---|:---|
| The Initial Consideration shall be paid as follows: | The Initial Consideration shall be paid as follows: |
| (i) | An amount of USD 150,000 of the Initial Consideration in cash (the ***Initial Cash Consideration***). |
| (ii) | The remaining portion of the Initial Consideration, that is, an amount of USD 290,000 (the ***Initial Equity Consideration***) in the form of newly issued shares of common stock of the Purchaser, each having a par value of $0.001 per share (the ***Initial Consideration Shares***). It is agreed that the number of Initial Consideration Shares is determined by dividing USD 290,000 by the average per share closing price of the Purchaser's common stock on Nasdaq during the seven trading days commencing on August 27, 2025 and ending on September 5, 2025, representing in the aggregate, immediately prior to the issuance of such shares at the Closing Date, no more than eight percent (8%) of the issued and outstanding shares of common stock of the Purchaser. Those shares shall be issued free of any Liens and encumbrances, fully paid, non-assessable, and not subject to any lock-up or resale restrictions other than those required by the applicable securities law, the Lock-Up Agreement and the Voting Agreement (both as defined herein). |
|  | The Parties expressly agree that the Initial Consideration Shares corresponding to: |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;■ Aargauische
 Kantonalbank (i.e., 3,540 shares) shall be issued to Mr. Timo Steitz, on behalf of Aargauische Kantonalbank;

■ SP
 ex Draze for ShoeSize.Me AG (i.e., 6,528) shall be issued to Mrs. Claudia Neuenschwander, on behalf of SP ex Draze for ShoeSize.Me AG.

Consequently, the number of Initial Consideration Shares issuable to each Seller shall be as set forth in Annex 3.3.1(ii).

Such issuance shall be deemed to fully satisfy the Purchaser's obligation to deliver the Initial Consideration Shares attributable to Aargauische Kantonalbank and SP ex Draze for ShoeSize.Me AG.

Mr. Timo Steitz shall assume the obligation to compensate Aargauische Kantonalbank, and Claudia Neuenschwander shall assume the obligation to compensate SP ex Draze for ShoeSize.Me AG, in each case by means of separate agreements to be entered into between them and their respective beneficiaries, on such terms as they may agree. Any such settlements shall be a matter solely between those parties and shall not give rise to any rights or obligations of the Purchaser.

Aargauische Kantonalbank, SP ex Draze for ShoeSize.Me AG, Timo Steitz and Claudia Neuenschwander hereby expressly acknowledge and agree that the Purchaser has no outstanding obligations whatsoever in respect of the Initial Consideration Shares, and irrevocably waive any right to bring or pursue any claim against the Purchaser, the Company or any of their employees or affiliates in this regard, confirming that all obligations relating to the Initial Consideration Shares are duly fulfilled.

3.3.2. It
 is acknowledged and agreed by the Parties that a portion of the Initial Cash Consideration
 shall be applied towards the settlement of certain fees and expenses payable by the Sellers
 to CORUM GROUP INTERNATIONAL, S.à.r.l. in connection with the transaction set forth
 herein, and which amount to USD 50,000 (the  ***Corum Fees***).

The Parties further acknowledge and agree that the Purchaser shall directly pay the Corum Fees to CORUM GROUP INTERNATIONAL, S.à.r.l. on behalf of the Sellers at Closing. Accordingly, the Initial Cash Consideration payable to the Sellers at Closing shall be reduced by an amount equal to the Corum Fees, resulting in a net cash amount of USD 100,000 to be paid to the Sellers (the ***Net Initial Cash Consideration***), and such direct payment to CORUM GROUP INTERNATIONAL, S.à.r.l. of the Corum Fees shall fully discharge the Purchaser's obligation towards the Sellers with respect to such amount.

---

| | |
|:---|:---|
| 3.4. | <u>Payment and settlement</u> |
| 3.4.1. | The Net Initial Cash Consideration shall be satisfied by the Purchaser to the Sellers on the Closing Date, by means of international irrevocable bank wire transfer to the bank account of the Majority Seller 3 as detailed in **Annex 3.4.1**. Immediately after receipt of the Initial Cash Consideration by the Majority Seller 3, but in no event later than seven |
|  | (7) days after, the Majority Seller 3 shall, by means of international irrevocable bank wire transfer, disburse to the bank accounts for each remaining Seller the correspondent part of the Net Initial Cash Consideration to the remaining Sellers, and according to the stake percentages set forth in Annex I. |
|  | The Parties expressly acknowledge and agree that, upon the Purchaser's payment of the Net Initial Cash Consideration to the Majority Seller 3 as set out above, the Purchaser shall be deemed to have fully and irrevocably discharged any and all of its payment obligations towards the Sellers in respect of the Net Initial Cash Consideration, and no Seller shall be entitled to bring any claim against the Purchaser in relation to such payment. |
| 3.4.2. | The number of Initial Consideration Shares issuable to the Sellers, shall be determined as of the Closing Date, according to the stake percentages set forth in Annex I. |
| 3.4.3. | Failure by the Purchaser to comply with any payment or settlement obligation set forth in this clause may give right to the Sellers to initiate the procedure for resolution of disputes set forth in clause 14.9. |
| **4.** | **CLOSING. CLOSING ACTIONS AND DELIVERIES. POST-CLOSING ACTIONS** |
| 4.1. | <u>Closing</u> |
| 4.1.1. | Subject to the terms and conditions set forth in the Agreement, the consummation of the Shares' sale and purchase (the ***Closing***) shall take place immediately after the execution/signing of this Agreement (same date) at the offices of MLL Legal Ltd or any other date and place as mutually agreed between the Parties in writing (the ***Closing Date***). |

---

4.2. <u>Closing actions and deliveries</u> 

4.2.1. All
 actions and deliveries described in this clause shall be deemed to be executed as a single act on the Closing Date. Consequently,
 such actions, without prejudice of being performed in unity with the other actions, shall be deemed to have been executed immediately
 prior to the formalization by the Parties of the effective transfer of the Shares. The Parties expressly acknowledge and agree that
 the execution on the Closing Date of each and every one of the actions provided for in this clause are essential obligations of the
 Agreement, and that none of them shall be deemed to have been performed until such time as each and every one of them has been completed.

4.2.2. **Sellers' actions and deliveries**. On the Closing Date, the Sellers (or the Sellers' Representative, as applicable) perform the following
 actions and/or present and deliver the following documents in connection with the transfer of Shares:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) **Assignment Declarations.** Each Seller delivers the original written assignment declarations in relation to the transfer and assignment of
 the Shares from each Seller to the Purchaser duly signed by or on behalf of each Seller (wet-ink).

(ii) **Board Resolution Approving the Transfer.** The Sellers' Representative delivers the original of the resolution of the board of
 directors of the Company approving the transfer of the Shares from the Sellers to the Purchaser and the acknowledgment of the Purchaser
 as sole shareholder of the Company with full voting rights.

(iii) **Share Register.** The Sellers' Representative delivers the original of the duly signed share register (*Aktienbuch*) of the
 Company reflecting the transfer of the Shares from each of the Sellers to the Purchaser and the registration of the Purchaser as
 the sole legal owner of the Shares with full voting rights.

(iv) **Letters of resignation**. The Sellers' Representative delivers to the Purchaser the original letters of resignation of all the members
 of the board of directors of the Company, duly signed by them (wet-ink), and by virtue of which, with effect from the Closing Date,
 they resign from their respective positions, and declare that they have no claims whatsoever against the Company for their services
 rendered to the Company in their capacity as members of the board of directors; for the avoidance of doubt, excluding and without
 reference or effect on any Preferred Sellers' Claims (as this term is defined below).

(v) **Waivers and communications.** The Sellers' Representative delivers to the Purchaser all waivers, consents, and notifications from
 third parties required in connection with the transactions contemplated in this Agreement, including any waivers of change of control
 clauses or similar rights, as well as any notices required to be sent to third parties, in each case in form and substance reasonably
 satisfactory to the Purchaser. In particular, the Sellers' Representative delivers to the Purchaser the duly signed waiver
 issued by the Management Agency Technology Fund and Corum Group (the latter expressly waiving any right to claim from the Sellers,
 the Company, and/or the Purchaser any amounts other than the Corum Fees).

(vi) **Lock-Up Agreement**. Each of the Majority Sellers shall have executed the Lock- Up Agreement
 in the form attached hereto as **Annex 4.2.2 (vi)** (the **Lock-Up Agreement**).

(vii) **Voting Agreement**. Each of the Majority Sellers shall have executed the Voting Agreement, in the form attached hereto as **Annex 4.2.2 (vii)** (the **Voting Agreement**).

4.2.3. **Purchaser's actions and deliveries**. On the Closing Date, the Purchaser performs the following actions and/or presents and delivers the following
 documents:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) **Internal approval**. The Purchaser provides evidence to the Sellers of having obtained the necessary approvals from its competent corporate
 bodies, as required under its bylaws or applicable law.

(ii) **Net Initial Cash Consideration**. The Purchaser pays to the Majority Seller 3 the Net Initial Cash Consideration, in accordance with
 clause 3.

(iii) **Issuance of Shares**. The Purchaser delivers to the Sellers' Representative an irrevocable instruction letter to the transfer agent,
 instructing the transfer agent to issue to each Seller, such Seller's Initial Consideration Shares.

(iv) **UBO Notification**. The Purchaser delivers to the Sellers' Representative a copy of the duly signed notification to the Company
 of the ultimate beneficial owner(s) of the Shares according to article 697j CO (*Meldung der an Aktien wirtschaftlich berechtigten Person(en)*).

(v) **Lock-Up Agreement**. The Purchaser shall have executed the Lock-Up Agreement.

(vi) **Voting Agreement**. The Purchaser shall have executed the Voting Agreement.

4.2.4. **Parties' actions and deliveries**. On the Closing Date, the Parties take the following actions and/or present and deliver the following
 documents in connection with the sale and purchase of the Shares:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) **Powers of attorney**. Each of the Parties, as appropriate, exhibits to the other Parties sufficient powers of attorney for the execution
 of the sale and purchase of the Shares and the performance of the other actions provided for in the Agreement.

(ii) **Closing Memorandum**. The Parties agree to record the actions taken at Closing Date as set out in these sections 4.2.2, 4.2.3 and 4.2.4
 in a closing memorandum. By executing the closing memorandum, the Parties confirm that all actions taken at the Closing Date are
 accepted by them to be in compliance with these sections 4.2.2, 4.2.3 and 4.2.4 and that the Closing has been completed.

(iii) **New board and management**. The Purchaser shall hold an extraordinary shareholders' meeting of the Company at which the new members
 of the governing body of the Company shall be elected. Thereafter, the newly elected members of the governing body shall take a resolution
 to appoint new members of the management and/or new signatories of the Company. The Purchaser undertakes to register the changes
 with the competent commercial register.

---

| | |
|:---|:---|
| 4.3. | <u>Post-Closing actions</u> |
| 4.3.1. | The Majority Sellers shall deliver to the Purchaser duly signed (digitally signed e.g. via Docusign) waiver declarations within 60 days after closing date, in the form attached hereto as **Annex 4.3.1.** signed by each current or former employee who has been granted options under the Company's stock option plan dated July 31st, 2015, confirming that no further claims exist in connection with such stock options plan. |
|  | Failure by the Majority Sellers to comply with this obligation shall entitle the Purchaser to seek full indemnification for any Losses incurred as a result thereof, pursuant to the indemnity provisions set forth in this Agreement. |
| 4.3.2. | **Due Diligence Process' materials**. The Parties shall jointly prepare and agree upon a comprehensive index of all documents and information made available in the virtual data room up to June 1, 2025, together with their content. Such data room materials, along with the agreed index, shall, unless already completed on the Closing Date, be transferred within five (5) business days thereafter, to two identical copies of a durable and non-alterable medium (such as encrypted USB devices) and signed off by the Parties as a true and complete record of the information disclosed. The Sellers' Representative and the Purchaser shall retain one copy of such medium, which shall be held in safekeeping by the respective Party or a mutually agreed trusted third party for a minimum period of ten (10) years from the Closing Date. |
| **5.** | **TRANSFER OF BENEFIT AND RISK. PREFERRED SELLERS' CLAIMS** |
| 5.1. | The risks and benefits of the Shares shall pass to the Purchaser on the Closing Date. |
| 5.2. | The Parties agree that profits generated in the current fiscal year 2025 as well as any profits that were generated in prior fiscal years but have not yet been distributed to the Sellers (i.e. profits carried forward from previous fiscal years and profits from previous fiscal years regarding which no distribution resolution has yet been passed) shall solely belong to the Purchaser. |
| 5.3. | Notwithstanding the foregoing, the Purchaser undertakes to procure that the Company, through the newly elected members of its governing body and/or management team, ensure that the claims due to the Sellers set forth in **Annex 5.3** (the ***Preferred Sellers' Claims***), are settled as soon as practicable following the Closing Date. In particular any income generated from the Company's accounts receivables shall be primarily applied to repay the Preferred Sellers' Claims until they have been settled in full. However, such application shall not prevent or delay the settlement of any liabilities which, pursuant to applicable law, contractual obligations of the Company, or any final and binding court or administrative order, must be discharged with priority. For the avoidance of doubt, nothing in this provision shall require the Purchaser and/or the Company to act in a manner that would place it in breach of applicable law, expose it to enforcement measures, or constitute a default under any of its material agreements in force. |
| **6.** | **SELLERS' LIABILITY REGIME** |
| 6.1. | Each of the Sellers hereby represents and warrants to the Purchaser that the Fundamental Representations and Warranties (as defined below) are true and correct and not misleading with respect to itself or the Company, respectively, as of the Closing Date. Each of the Majority Sellers further represents and warrants to the Purchaser that the Business Representations and Warranties are true and correct and not misleading with respect to itself or the Company, respectively, as of the Closing Date. |

---

---

| | |
|:---|:---|
| 6.2. | The Sellers shall be severally and not jointly liable —prorate to their stake in the Company's share capital according to Annex I—, under the terms and conditions set forth in this clause, to indemnify the Purchaser and/or the Company, irrespective of any fault, for any Losses (as this term is defined below) incurred or sustained by the Purchaser and/or the Company, as the case may be, resulting from or arising out of any misrepresentation, inaccuracy or breach of the representations and warranties contained in **Annex 6.2** (the ***Fundamental Representations and Warranties***). |
| 6.3. | Additionally, the Majority Sellers shall be severally and not jointly liable —prorate to their stake in the Company's share capital according to Annex I—, under the terms and conditions set forth in this clause, to indemnify the Purchaser and/or the Company, irrespective of any fault, for any Losses (as this term is defined below) incurred or sustained by the Purchaser and/or the Company, as the case may be, (i) resulting from or arising out of any misrepresentation, inaccuracy or breach of the representations and warranties contained in **Annex 6.3** (the ***Business Representations and Warranties***), |
|  | (ii) in connection with any act, omission, event or circumstance that occurred or existed prior to the Closing Date, and (iii) from the failure to comply with any of the obligations assumed by them by virtue of the Agreement (including non-compete obligation). |
| 6.4. | In addition, the Majority Sellers shall, defend, indemnify, keep indemnified and hold harmless the Company, the Purchaser and/or their respective Affiliates from and against any and all Losses arising out of or in connection with any claim by any current or former participant or beneficiary under the Company's stock options plan dated July 31st, 2015, including without limitation any claim relating to ungranted, unvested, or unsettled options or similar rights. This indemnity shall survive shall not be subject to any material, temporary and/or qualitative limits applicable to other indemnities under this Agreement or under the CO and are due irrespective of any fault by the Majority Sellers or of any actual or deemed knowledge by the Purchaser. The indemnity obligations under this clause 6.4 shall expire after 10 (ten) years following the Closing Date. For the avoidance of doubt, the Parties acknowledge and agree that the limitations set forth in clauses 6.8, 6.10, 6.12, 6.13 shall not be applicable to any claim under this section 6.4. |
| 6.5. | Likewise, the Majority Sellers shall defend, indemnify, keep indemnified and hold harmless the Company, the Purchaser and/or their respective Affiliates from and against any and all Losses that arise from, are based upon, or are in any way related to: |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) the
 existence, ownership, management, or operations of the Spanish wholly owned subsidiary of the Company, **NUMERO DE CALZADO, S.L.**,
 company of Spanish nationality, with registered address at Barcelona (Spain), Estruch 9 (08001), holder of Spanish Tax I.D. number
 B-66422882, and registered within the Commercial Register of Barcelona, Volume 44,609 , Page 132, Sheet B- 461,083; at any time on
 or prior to the date of its complete and effective dissolution, liquidation, and cancellation of its registration with the Commercial
 Registry of Barcelona; and/or

(ii) the
 process of regularizing, managing, dissolving, liquidating, and winding-up the Spanish Subsidiary.

---

| | |
|:---|:---|
|  | This indemnity shall be subject to any material, temporary and/or qualitative limits set forth in clauses 6.8, 6.10, 6.12, 6.13. The indemnity obligations under this clause 6.5 shall expire after 10 (ten) years following the Closing Date. |
| 6.6. | This is without prejudice to the obligation of the Sellers to indemnify the Purchaser for the breach of any other obligations, commitments or agreements established in the Agreement. |
| 6.7. | Sellers' liability for Losses shall not be affected or limited by the completion by the Purchaser of the Due Diligence Process. The Parties therefore agree that article 200 CO shall be excluded and not be applicable to this Agreement. |
| 6.8. | Notwithstanding the foregoing, the Sellers shall not be liable in respect of (a) any claim related to the Santoni-legal case or (b) any Direct Claim to the extent —and only to the extent— that the fact, matter, circumstance or occurrence giving raise to such Direct Claim (i) was fairly disclosed in the Due Diligence Process in sufficient detail to enable a reasonably prudent purchaser to identify the nature and scope of the matter in question, and (ii) was within the Purchaser's knowledge. However, the Purchaser's knowledge shall not limit or exclude the Sellers' Liability in respect of any Third-Party Claim, even if the underlying fact, matter, circumstance or occurrence giving rise to such Third-Party Claim was within the Purchaser's knowledge. |
|  | For the purposes of the Agreement, ***Purchaser's Knowledge*** means the actual, conscious awareness (and not imputed, constructive or deemed knowledge) of the Purchaser or any of its representatives, of a fact, matter, circumstance or occurrence, that has been disclosed during the Due Diligence Process in the virtual data room operated via dealroom.co by the Company for this purpose, and contained in the durable and non-alterable medium mentioned in clause 4.2.4 (v), provided such information was disclosed in a manner and to a level of detail that makes the nature and potential impact of the relevant matter reasonably apparent, that is, in a fair and non-misleading manner which would allow the Purchaser to fairly asses and qualify the impact of such fact, matter or circumstance on the business operations, prospects and the valuation of the Company to which such matter, fact, circumstance or occurrence relates, upon first reading and without making any further inquiries or cross examinations of other documents to identify and accurately assess the fact or matter concerned. |
| 6.9. | For the purposes of the Agreement, ***Loss*** or ***Losses*** shall be understood to mean any losses or damages, costs, obligations, liabilities, fines, interest, payment, penalty, tax or expenses of any kind (including reasonable attorneys, court agents, notaries, auditors, accountants and experts' fees or cost incurred). |
| 6.10. | The Majority Sellers' liability set forth in clause 6.3 shall be excluded or reduced, as the case may be, if, and to the extent that: |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Those
 Losses were expressly identified and provisioned in the last financial statements of the Company as of 31 December 2024, provided
 that they are identified and for the amount expressly provided;

(ii) Those
 Losses are attributable to any loss of profits and/or opportunity costs, moral or reputational damages, indirect losses or damages
 due to an alleged frustration of expectations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) Those
 Losses result from any change in accounting or taxation legislation coming into effect after the Closing Date; or due to any change
 in a law or applicable rule or regulation, occurring after the Closing Date; or,

(iv) Those
 Losses are effectively recovered by the Company and/or the Purchaser from any third party (including insurance companies).

6.11. The
 limitations stated under clause 6.10 above shall neither apply (i) with respect to the Fundamental Representations and Warranties;
 nor (ii) with regard to the Business Representations and Warranties set forth in Annex 6.3 section 8 (IP Rights), nor (iii) in case
 of fraud (*Betrug*) or willful misconduct (*absichtliche Täuschung*).

6.12. <u>Material limits</u> 

6.12.1. Sellers'
 obligation to compensate for Losses is subject to the following material limits, unless in case of fraud (*Betrug*) or willful
 misconduct (*absichtliche Täuschung*) of a Seller:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) The
 maximum liability amounts payable by the Sellers to the Company and/or the Purchaser shall not exceed one hundred percent (100%)
 of the sum of: (i) the Initial Equity Consideration, as stated in clause 3.3.1 and (ii) the Initial Cash Consideration.

(ii) The
 Sellers shall not be liable for any claim for Losses unless:

---

| | |
|:---|:---|
| a. | Such particular Loss exceeds CHF 3,500 (the ***De Minimis***). |
|  | For the avoidance of doubt, series of Losses having the same origin or nature shall be deemed as an individual Loss for the purposes of this paragraph and, therefore, as a Loss, even if each or some of the individual Losses belonging to the series do not exceed the aforementioned amount. |

---

---

| | |
|:---|:---|
| b. | The aggregate of Losses also exceeds the amount of CHF 35,000 (the ***Basket***). |
|  | In such a case, the Sellers must indemnify the Purchaser for all the Losses that has been occasioned from the first CHF, and not only for the amount by which it exceeds the Basket. |

---

6.12.2. The
 limitations set forth in this clause shall not apply (i) with respect to Fundamental Representations and Warranties or (ii) with
 regard to the Business Representations and Warranties set forth in Annex 6.3 section 6 (Tax Matters) and 10 (Social Security Matters).

6.12.3. Purchaser
 agrees that it may not recover twice the same Losses against any Seller.

6.13. <u>Temporary limits</u> 

6.13.1. Notwithstanding
 the provisions of the preceding paragraphs, claims of the Purchaser against each Seller for a misrepresentation, inaccuracy or breach
 of the Sellers' Representations and Warranties shall be time-barred (*verjährt*):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. With
 respect to Fundamental Representations and Warranties made in Annex 6.2, as from 10 (ten) years following the Closing Date;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. With
 respect to the Business Representations and Warranties made in Annex 6.3, section 5 (Tax Matters) and 9 (Social Security Matters)
 6 (six) months after the final and binding and non-appealable assessment of the relevant Taxes or social security contributions;
 and,

c. With
 respect to all other Business Representations and Warranties made in Annex 6.3 as from 24 (twenty-four) months following the Closing
 Date.

---

| | |
|:---|:---|
| 6.13.2. | Any claim by the Purchaser against the Seller under this clause 6 shall not be precluded or time-barred (*verjährt*) if the Purchaser commence the proceedings against the Sellers in accordance with Annex 6.15 before the expiration of the time limitation set forth above. Further, for the avoidance of doubt, the time periods to bring claims against the Sellers shall remain in place and/or be prolonged accordingly, if the proceedings under Annex 6.15 and/or any formal administrative, settlement, court, arbitration or other proceedings between the Purchaser or the Company and the relevant Governmental Authority or third parties are pending. |
| 6.14. | <u>Indemnity payment</u> |
|  | If the Loss is suffered by the Purchaser, the compensation for the Loss shall be made by the Sellers to the Purchaser. If the Loss is suffered by the Company, the indemnity shall be made by the Sellers to the Company and/or the Purchaser, at the latter's discretion. |
| 6.15. | <u>Claim procedure</u> |
|  | The obligation of the Sellers to indemnify the Purchaser or the Company under any of the provisions set forth in this clause will be subject to the claim procedure set out in **Annex 6.15.** The deadlines and obligations under articles 201 and 210 para. 1 and 2 CO are waived and replaced in full by the provisions of clause 6.4, 6.13 and Annex 6.15. |
| **7.** | **PURCHASER'S REPRESENTATIONS AND WARRANTIES** |
| 7.1. | The Purchaser hereby represents and warrants to the Sellers that the following is true and correct and not misleading as of the Closing Date (the ***Purchaser's Representations and Warranties***): |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) It
 has the full power and authority to execute this Agreement and, if applicable, the rest of the Transaction Documents to which it
 is a party, and to consummate the transactions contemplated hereby and thereby;

(ii) The
 execution of the Agreement and, if applicable, the rest of the transaction documents to which it is a party has been authorized by
 all necessary corporate actions, where required, on its part;

(iii) The
 Agreement constitutes a valid and binding obligation of the Purchaser and is enforceable
 against it in accordance with its respective terms, all except as may be limited by (i) applicable
 bankruptcy, insolvency, reorganization, moratorium, and other laws of general application
 affecting enforcement of creditors' rights, and (ii) as limited by laws relating to
 the availability of specific performance, injunctive relief, or other equitable remedies.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) The
 Initial Consideration Shares, when issued pursuant to this Agreement shall be duly authorized, validly issued, fully paid and nonassessable
 and issued in compliance with all applicable federal and state securities laws.

7.2. The
 Purchaser agrees to indemnify the Sellers for any Loss the Sellers may suffer as a result of the lack of veracity or inaccuracy of
 the Purchaser's Representations and Warranties. This indemnification obligation shall survive and remain in full force and
 effect until the first anniversary of the Closing Date, provided that if, at any time prior to the expiry of such period, any of
 the Sellers delivers to the Purchaser a written notice asserting a claim under this clause, then the claim asserted in such notice
 shall survive the first anniversary of the Closing until the claim notice is fully and finally resolved.

**8.** **CONFIDENTIALITY** 

8.1. Parties
 undertake not to make public (by way of an announcement or by press release or in any other manner) the identity of the Purchaser,
 the Share's sale and purchase, this Agreement (including its existence), or the terms hereof without the other Parties'
 prior written consent, unless any applicable law or regulation or judicial or administrative order requires any publication or disclosure
 thereof, in which case the Parties agree to notify each other in advance of any such request and to limit any disclosure of information
 relating to the Company's valuation and, in particular, the amount of the Initial Consideration, to the absolute minimum necessary
 to comply with such requirement.

8.2. Notwithstanding
 the foregoing, the Parties may disclose to any of their directors, officers, employees, auditors and advisors those aspects of the
 Agreement that they deem necessary for its compliance, subject to the signing of a confidentiality agreement.

8.3. In
 addition, the Parties undertake, regarding the Company and its Activity, to: (i) keep absolutely confidential all knowledge, data
 and economic, technical, technological, know- how, research, R&D, administrative, commercial relations, commercial and productive
 strategies regarding the, which they have or have access, and (ii) not use the information received to carry out, directly or indirectly
 through third parties, activities that may interfere or in any other way harm the Company or its Activity.

8.4. In
 view of the fact that Purchaser is a public company traded on the NASDAQ, the execution of the Agreement and discussions relating
 thereto may be deemed to constitute material non-public information under the United States securities laws (the  ***Securities Law***). The Sellers, the Company and their representatives who are informed as to the subject matter of this Agreement shall
 not trade in the securities of Purchaser or otherwise carry out any act or omission that may constitute use of inside information
 or material non-public information in violation of the Securities Law.

**9.** **NON-COMPETE** 

9.1. As
 of the Closing Date and for the period of two (2) years thereafter, each Majority Seller hereby undertakes not to, directly or indirectly,
 either alone or jointly with any other person or in any capacity whatsoever:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Solicit,
 induce or persuade (or attempt to do the same) any supplier, customer, affiliate and/or partner of the Company or its subsidiaries
 to terminate, alter or otherwise reduce the scope of its business relationship with the Company and/or any Affiliate;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Carry
 on, operate, manage, be engaged or economically interested in, (whether as a shareholder, director, officer, employee, consultant
 or otherwise) a business competing with the Activity, as currently conducted or as expected to be conducted.

(iii) Solicit,
 induce or persuade (or attempt to do the same) any senior employee, director, executive, or consultant of the Company or its subsidiaries
 to leave the employ of, and/or terminate its engagement with, the Company or any of its Affiliates;

(iv) Solicit
 for employment, hire or engage as an independent contractor, any employee or independent contractor of the Company or of any of its
 Affiliates;

9.2. The
 above restrictions shall not prohibit any Seller from holding up to five percent (5%) of the outstanding issued share capital of
 a competing company listed on any recognized stock exchange, solely as a passive financial shareholder.

9.3. The
 Parties acknowledge and agree that the restrictions contained in this clause are no greater than is reasonably necessary for the
 protection of the interests of the Purchaser, and the Company.

9.4. In
 the event of a breach by any of the Majority Sellers of the non-compete obligation set out in this Agreement, and without prejudice
 to the general liability regime and any other remedies available to the Purchaser under this Agreement, the breaching Seller shall
 pay to the Purchaser, as liquidated damages, an amount equal to twice the Initial Consideration actually received by such Seller
 under this Agreement for each violation or breach. The payment of the liquidated damages shall not release the breaching Seller from
 its obligations under this Agreement and actions for performance and claims for further damages by the Purchaser expressly remain
 reserved.

**10.** **INTEREST** 

10.1. If
 either the Purchaser or any of the Sellers defaults in the payment when due of any sum payable under this Agreement (whether determined
 by agreement or pursuant to an order of a court or otherwise), the liability of the relevant Party shall be increased to include
 interest on such sum from the date when such payment is due until the date of actual payment (as well after as before judgement)
 at a simple non-compounding interest rate of four percent (4%) per annum.

**11.** **CURRENCY AND EXCHANGE RATE** 

11.1. All
 amounts payable under this Agreement shall be denominated and settled in United States dollars (USD).

11.2. Notwithstanding
 that the accounting records of the Company are maintained in Swiss francs (CHF), for the purpose of determining any amount correspondent
 by virtue of this Agreement, all figures derived from such records shall be converted into USD.

11.3. Such
 conversion shall be made using the exchange rate published by the European Central Bank
 (or, if unavailable, any other internationally recognized source agreed between the Parties) on the Business Day immediately preceding
 the Closing Date, unless otherwise agreed in writing by the Parties or, where applicable, on the Business Day immediately preceding
 the date on which the relevant amount has to be settled.

**12.** **SELLERS' REPRESENTATIVE** 

12.1. The
 Sellers hereby appoint Mr. Timo Steitz as their representative for the purposes of this Agreement (the  ***Sellers' Representative***),
 granting him all necessary powers to act on behalf of the Sellers and to perform all acts necessary or convenient for the implementation
 of this Agreement, and in particular:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) To
 sign, on behalf of the Sellers, any contracts or documents contemplated under this Agreement;

(ii) To
 receive from or send to the Purchaser, and/or to the person or entity responsible for dispute resolution, any notices and/or communications;
 and

(iii) To
 represent the Sellers to the fullest extent in any matters related to this Agreement.

12.2. In
 accordance with the foregoing: (i) any notice, communication and/or act from the Purchaser addressed to the Sellers' Representative
 (including, without limitation, any communication or claim addressed to the Sellers) shall be deemed to have been made or carried
 out in respect of all the Sellers (or, where applicable, in respect of any of them individually); (ii) any notice, communication
 and/or act from the Sellers to the Purchaser shall only be valid if made or carried out by the Sellers' Representative, in
 which case it shall be deemed to have been made by all the Sellers (or the Majority Sellers, where applicable); and (iii) any act
 or document executed, granted or signed by the Sellers' Representative under this Agreement shall be deemed to have been executed,
 granted or signed by all the Sellers (or their respective successors or assigns).

12.3. The
 Sellers may replace the Sellers' Representative with another person, provided that such replacement shall not be effective
 until the Purchaser has received, in accordance with the terms of this Agreement, a notice signed by all the Sellers, together with
 the necessary contact details of the new representative for the purpose of notices and communications.

**13.** **SOLE REMEDY** 

13.1. Unless
 expressly set forth otherwise in the Agreement, the Parties expressly agree that all the remedies contained therein are the only
 ones that the Parties may enforce against each other, thereby comprising the entire compensation regime for any Loss regarding the
 sale and purchase of Shares subject matter of the Agreement. Accordingly, the parties hereby expressly renounce, in the broadest
 terms allowed by law, the right to exercise any action to claim against any other Party, different from those set out in the Agreement
 that, without such renunciation, might be entitled to exercise under the applicable law.

**14.** **MISCELLANEOUS** 

14.1. <u>Costs</u>.
Each of the Sellers (on the one hand) and the Purchaser (on the other hand) shall be responsible for its own costs and expenses in connection
with the transaction contemplated herein. Any Swiss securities transfer tax (*Umsatzabgabe*), if any, incurred in connection with
the transfer of the Shares shall be borne by the Party legally subject to such tax.

14.2. <u>Further Assurances</u>. Each of the Parties hereto shall perform such further acts and execute such further documents as may reasonably be
 necessary to carry out and give full effect to the Shares' sale and purchase, the provisions of this Agreement and the intentions
 of the parties as reflected thereby.

14.3. <u>Assignment</u>.
 Except as otherwise expressly limited herein, the provisions hereof shall inure to the benefit of, and be binding upon, the successors,
 assigns, heirs, executors, and administrators of the Parties. None of the rights, privileges, or obligations set forth in, arising

 Sellers, with the exception of an assignment or transfer from the Sellers or the Purchaser to any entity Controlling, Controlled
 by or under common Control therewith.

14.4. <u>Entire Agreement</u>. This Agreement and the schedules hereto constitute the full and entire understanding and agreement between the Parties
 with regard to the subject matters hereof and any other written or oral agreement relating to the subject matter hereof existing
 between the Parties is expressly canceled, including the Term Sheet dated March, 2025.

14.5. <u>Amendments</u>.
 Any term of this Agreement may be amended only with the express and unanimous written consent of the Parties.

14.6. <u>Notices</u>.
 All notices and other communications required or permitted hereunder to be given to a Party to this Agreement shall be in writing
 and shall be addressed to such Party's address as set forth below or at such other address as the Party shall have furnished
 to each other Party. Any such notice or communication shall be delivered by any means (whether physical or electronic) that allows
 evidence of its receipt by the recipient.

14.7. <u>Delays or omissions</u>. No delay or omission to exercise any right, power, or remedy accruing to any Party upon any breach or default under
 this Agreement, shall be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver on the part
 of any Party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically
 set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any of the Parties, shall
 be cumulative and not alternative.

14.8. <u>Severability</u>.
 If any provision of this Agreement is held by a court of competent jurisdiction to be unenforceable under applicable law, then such
 provision shall be amended to the maximum extent required to render it valid, legal and enforceable (or deleted if no such amendment
 is feasible), and such amendment or deletion shall not affect the enforceability of the other provisions hereof.

14.9. <u>Governing Law and jurisdiction</u>. All questions concerning the construction, validity, enforcement and interpretation of the Agreement shall
 be governed by and construed and enforced in accordance with the substantive laws of Switzerland, excluding its rules on conflict
 of laws and excluding international treaties. Any dispute, controversy or claim arising out of, in connection with or relating to
 this Agreement, including without limitation, disputes, controversies or claims regarding the validity, invalidity, breach or termination
 thereof, shall be finally resolved by arbitration in accordance with the Swiss Rules of International Arbitration of the Swiss Chambers'
 Arbitration Institution in force on the date on which the Notice of Arbitration (as such term is defined in the Swiss Rules of International
 Arbitration of the Swiss Chambers' Arbitration Institution) is submitted in accordance with such rules. The number of arbitrators
 shall be three. The seat of the arbitration shall be Zurich. The arbitral proceedings shall be conducted in English.

14.10. <u>Electronic execution</u>. This Agreement and any other documents relating to this Agreement, and any amendments or supplements thereto or mutually
 agreed cancellation thereof, shall be treated as a handwritten original delivered in person, to the extent that they are executed
 (i) using an electronic signature (such as DocuSign, Skribble or Adobe Sign, whether or not the electronic signature is issued by
 a provider recognized or accredited under applicable law) or (ii) by email delivery of a hand-signed PDF; unless this Agreement expressly
 provides that any document hereunder must be executed in handwritten (wet-ink) form.

**IN WITNESS WHEREOF**, the Parties execute this Agreement in the capacities in which they act, on the Closing Date.

---

| | | |
|:---|:---|:---|
| **MYSIZE INC.** | **MYSIZE INC.** |  |
| By: | */s/ Ronen Luzon* | */s/ Mr. Timo Steitz* |
| Title: | Chief Executive Officer |  |
|  | */s/ Mr. Wilhelm Steitz* | */s/ Mr. Ettore Weilenmann* |

---

**LIST OF ANNEXES**

---

| | |
|:---|:---|
| **Annex 0** | List of Sellers |
| **Annex I** | Distribution of the share capital |
| **Annex 1.1** | Definitions |
| **Annex 1.2** | Rules of interpretation |
| **Annex 3.3.1(ii)** | Initial Consideration Shares distribution |
| **Annex 3.4.1** | Bank accounts' details |
| **Annex 4.2.2 (vi)** | Lock-Up Agreement |
| **Annex 4.2.2 (vii)** | Voting Agreement |
| **Annex 4.3.1** | Waiver template related to the Company's stock options plan |
| **Annex 5.3** | Preferred Sellers' Claims |
| **Annex** **6.2** | Fundamental Representations and Warranties |
| **Annex 6.3** | Business Representations and Warranties |
| **Annex 6.15** | Claim procedure |

---

**Annex 0**

**List of Sellers**

[\*\*\*]

**Annex 1**

**Distribution of the share capital**

[\*\*\*]

**** 

<br> **Annex 1.1 Definitions**

---

| | |
|:---|:---|
| **Accounting Rules** | shall mean the accounting rules and principles set forth in the CO. |
| **Activity** | has the meaning assigned in Exhibit II. |
| **Affiliate** | shall mean with respect to any particular Person, any Person that, directly or indirectly, through one or more intermediaries, controls, is controlled by or is under common control with, such Person. |
| **Agreement** | has the meaning assigned in Exhibit V. |
| **Basket** | has the meaning assigned in clause 6.12.1 (ii) b. |
| **Business Day** | means any other day than Saturday, Sunday or bank holiday in the city of Zurich. |
| **Business IT** | shall mean all Information Technology which is owned or licensed by the Company and/or which has been used in the Ordinary Course of Business. |
| **Business** **Representations and Warranties** | has the meaning assigned in clause 6.3. |
| **Closing** | has the meaning assigned in clause 4.1.1. |
| **Closing Date** | has the meaning assigned in clause 4.1.1. |
| **CO** | shall mean the Swiss Code of Obligations. |
| **Company** | has the meaning assigned in Exhibit I. |
| **Control** | means the ability to direct, or cause the direction of, the management and policies of the relevant entity, whether through the ownership of voting securities, by contract or otherwise, including through the beneficial ownership of more than fifty percent (50%) of the ownership interests or voting rights or the right to appoint the majority of the directors (or the equivalent thereof) therein. |
| **Corum Fees** | has the meaning assigned in clause 3.3.2. |
| **CPC** | shall mean the Swiss Civil Procedure Code. |
| **Data Protection Regulations** | shall have the meaning set forth in Annex 6.3. |
| **Defense Completion Notice** | has the meaning assigned in Annex 6.15. |

---

---

| | |
|:---|:---|
| **De Minimis** | has the meaning assigned in clause 6.12.1 (ii) a. |
| **Direct Claim** | has the meaning assigned in Annex 6.15. |
| **Due Diligence Process** | has the meaning assigned in Exhibit III. |
| **Financial Statements** | shall have the meaning set forth in Annex 6.2. |
| **Fundamental** **Representations and Warranties** | has the meaning assigned in clause 6.2. |
| **Governmental Authority** | shall mean (i) any sovereign political division or political subdivision thereof; (ii) any government thereof (whether federal, state, local or foreign) or any department, agency, bureau, commission, office, service, regulatory body or other instrumentality of government; or<br> (iii) any court or quasi-judicial (whether public or private, including any arbitration tribunal). |
| **Independent Expert** | shall mean expert different from the Company's audit firm (or legal advisors, where applicable), chosen by mutual agreement between the Parties (in the event that there is no agreement between the Parties on the appointment of the same, the one appointed by the Purchaser). |
| **Information Technology** | shall mean information systems, communication systems, or a computer system, including software, data, databases, data communication lines, systems, network and telecommunications equipment, Internet-related information technology infrastructure, wide area network, hardware and peripheral equipment. |
| **Initial Consideration** | has the meaning assigned in clause 3.3.1. |
| **Initial Consideration Shares** | has the meaning assigned in clause 3.3.1 (ii). |
| **Initial Cash Consideration** | has the meaning assigned in clause 3.3.1 (i). |
| **Initial Equity Consideration** | has the meaning assigned in clause 3.3.1 (ii). |
| **IP-Rights** | shall mean, in any jurisdictions, any trademarks, patents, service marks, service names, trade names, domain names, logos, inventions, trade secrets and other rights in know-how, design rights, utility models, copyrights (including software), rights in databases and all other similar proprietary rights, including, any registration of such rights and applications including provisional applications and rights to apply for such registrations, patents, and patent applications (including all reissues, divisions, renewals, extensions, provisionals, continuations and continuations-in-part thereof) and all other intellectual property rights. |

---

---

| | |
|:---|:---|
| **Law** | shall mean any federal, state, local, foreign or other law or governmental requirement of any kind, and the rules, regulations, statutes, Permits and Orders promulgated thereunder. |
| **Licensed IP-Rights** | shall have the meaning set forth in Annex 6.3. |
| **Lien** | shall mean any lien, charge, encumbrance and security interest, irrespective of whether such Lien arises under any agreement or by operation of statutory law. |
| **Lock-up Agreement** | has the meaning assigned in clause 4.2.2 (vi). |
| **Loss/es** | has the meaning assigned in clause 6.9. |
| **Majority Seller/s** | has the meaning assigned in PARTIES. |
| **Majority Seller 3** | has the meaning assigned in PARTIES. |
| **Material Adverse Change** | shall mean any change, event, violation, inaccuracy, circumstance or effect that is materially adverse to the business, financial conditions, capitalization, assets, liabilities, operations, or results of operations of the Company. |
| **Material Contract** | shall have the meaning set forth in Annex 6.3. |
| **Net Initial Cash Consideration** | has the meaning assigned in clause 3.3.2. |
| **Notice of Direct Claim** | has the meaning assigned in Annex 6.15. |
| **Notice of Disagreement with the Defense Completion Notice** | has the meaning assigned in Annex 6.15. |
| **Notice of Third-Party Claim** | has the meaning assigned in Annex 6.15. |
| **Open Source Software** | shall have the meaning set forth in Annex 6.3 |
| **Order** | shall mean (i) any order, judgment, decree, decision, ruling, writ, assessment, charge, stipulation, injunction or other determination of any Governmental Authority (including any arbitration award rendered by an arbitrator) having competent jurisdiction to render such; and (ii) any settlement agreement entered into in connection with the settlement, dismissal or other resolution of any Proceeding. |

---

---

| | |
|:---|:---|
| **Ordinary Course of Business** | shall mean the ordinary course of business of the Company, consistent with its past custom and practice (including with respect to quantities and frequencies), but excluding any action or omission that constitutes (or, with the passage of time, the giving of notice by any Person or the happening of any other event, would constitute) a breach of any contract or warranty, a tort, an infringement of any right of any other Person or a violation of Law. |
| **Owned IP-Rights** | shall have the meaning set forth in Annex 6.3. |
| **Party/ies** | means the Sellers and the Purchaser. |
| **Permit** | shall mean any written approval, consent, exemption, franchise, accreditation, license, permit, waiver, registration, filing, certificate or other authorization required by Law or any Governmental Authority. |
| **Person** | shall mean an individual (natural) person, a partnership, a corporation, an association, a limited liability company, a joint stock company, a trust, a joint venture, an unincorporated organization, a Governmental Authority or any other entity. |
| **Proceeding** | shall mean any charge, complaint, action, suit, litigation, proceeding, hearing, investigation, assessment or claim, or any notice of any of the foregoing, by or before any Governmental Authority. |
| **Proprietary Software** | shall have the meaning set forth in Annex 6.3. |
| **Purchaser** | has the meaning assigned in PARTIES. |
| **Purchaser's Knowledge** | has the meaning assigned in clause 6.8. |
| **Purchaser's** **Representations and Warranties** | has the meaning assigned in clause 7.1. |
| **Related Party/ies** | shall mean (i) any Affiliate of the Sellers; (ii) any director, manager, officer or employee of the Sellers (or of any of their Affiliates); and<br> (iii) any family member of any of the foregoing who is a natural person. |
| **Securities Law** | has the meaning assigned in clause 8.4. |
| **Seller/s** | has the meaning assigned in PARTIES. |
| **Sellers'** **Representations and Warranties** | means the Fundamental Representations and Warranties and Business Representations and Warranties |

---

---

| | |
|:---|:---|
| **Sellers' Representative**<br>| has the meaning assigned in clause 12.1. |
| **Shares** | has the meaning assigned in Exhibit I. |
| **Taxes** | shall mean all tax liabilities, including income taxes (personal or corporate), capital taxes, stamp duties (both on the issuance and on the transfer or securities), withholding taxes, value added taxes and all other taxes payable to any competent taxing authority in any jurisdiction, as well as any interest, penalties, costs and expenses reasonably related thereto. |
| **Third-Party Claim** | has the meaning assigned in Annex 6.15. |
| **Transaction Documents** | shall have the meaning set forth in Annex 6.2. |
| **Voting Agreement** | has the meaning assigned in clause 4.2.2 (vii). |

---

**Annex 1.2**

**Rules of interpretation**

a) The
 preliminary remarks contained in the Exhibitions and the content of any Annexes to the Agreement shall be deemed an integral part
 of the Agreement.

b) References
 to a person shall be construed so as to include any individual, firm, company, government, state or agency of a state or any joint
 venture, association, partnership, works council or employee representative body (whether or not having separate legal personality)
 and shall include any of its successors and permitted assigns thereof.

c) Unless
 otherwise specified, references made to "clauses" shall be understood to mean clauses of the Agreement.

d) Unless
 the context or the expressed provision of this Agreement otherwise require, headings and subheadings of the paragraphs and/or provisions
 contained herein are for convenience and reference purposes only and shall not have any effect on the meaning or construction of
 any of the provisions hereof.

e) Unless
 expressly specified, the use of "*or*" is not intended to be exclusive.

f) The
 words "*include*," "*includes*" and "*including*" are deemed to be followed by
 the words "*without limitation* ".

g) Any
 Exhibit or Annex to this Agreement shall take effect as if set out in the Agreement and references to the Agreement shall include
 its Exhibits and Annexes. If any conflict arises between the clauses in the Agreement and the content of its Exhibits, Annexes or
 any complementary document, the terms, spirit and object of the clauses of the Agreement shall prevail, unless it is otherwise expressly
 provided.

h) The
 expression "*for the avoidance of doubt*" shall have full binding force and effect, and constitute clarifications
 or specifications of which do not prejudice the generality of the provisions referred to.

i) Except
 where the context specifically requires otherwise, words importing one gender shall be treated as importing any gender, words importing
 individuals shall be treated as importing corporations and vice versa, words importing the singular shall be treated as importing
 the plural and vice versa, and words importing the whole shall be treated as including a reference to any part thereof.

**Annex 3.3.1(ii)**

**Initial Consideration Shares distribution**

[\*\*\*]

**Annex 3.4.1**

**Bank accounts' details**

[\*\*\*]

**Annex 4.2.2(vi)**

[\*\*\*]

**Annex 4.2.2(vii)**

[\*\*\*]

**Annex 4.3.1**

**Waiver template related to the Company's stock options plan**

**ShoeSize.Me** **AG**

Leberngasse 19

4600 Olten

(**Company**)

Place:   Date:  

**WAIVER**

To the Board of Directors of the Company, with reference to:

(i) that
 certain stock option plan of the Company dated 31 July 2015 (**Stock Option Plan**); and

(ii) those
 certain letter(s) of assignment entered between the Company and me dated (each a **Letter of Assignment**);

I, ________________________, hereby confirm that I was granted ______________options under the Stock Option Plan (**Options**).

I hereby agree to waive all rights and claims in connection with the ______________ Options granted to me under the Stock Option Plan (to the extent still existing as of the date hereof), whether vested or not, whether exercisable or not. All vested Options shall be deemed to have been re-assigned to the Company and, thus, lapsed. I acknowledge and agree that no Options are/will be exercisable by me at any time.

I agree not to receive any consideration from the Company for my waiver of the Options.

I further agree that all past, present, and future claims in connection with the Stock Option Plan as well as the Letter of Assignment are hereby settled and that I will not assert any further claims in this connection.

This waiver is governed by substantive Swiss law, to the exclusion of the UN Convention on Contracts for the International Sale of Goods (CISG) and any rules of collision of laws and international treaty. Any dispute, controversy or claim arising out of or in connection with this waiver shall be subject to the exclusive jurisdiction of the courts of the Canton of Zurich, with the place of jurisdiction being Zurich 1, Switzerland.

Name:

---

| |
|:---|
| **Noted and acknowledged by:** |
| **ShoeSize.Me AG** |

---

    <br> Name: Name:

**Annex 5.3**

[\*\*\*]

**Annex 6.2**

**Fundamental Representations and Warranties**

**Annex 6.2**

**Fundamental Representations and Warranties**

**1.** **Sellers' Capacity and Authority** 

1.1 With
 respect to each Seller that isa natural person, each Seller is competent and has full power, right and authority to enter into and
 perform its obligations under this Agreement and each of the ancillary agreements (**Transaction Documents**) to which it is a
 party.

1.2 Each
 Seller that is a legal entity is duly incorporated, validly existing and, where applicable, in good standing under the laws of its
 jurisdiction of incorporation. It has full corporate power and authority, duly authorized by all necessary corporate actions, to
 enter into this Agreement and each of the Transaction Documents to which it is a party, and to perform its obligations thereunder
 and hereunder. The signatories acting on behalf of such Seller are duly authorized.

1.3 This
 Agreement constitutes the legal, valid and binding obligation of each Seller, enforceable against each Seller in accordance with
 its terms, except to the extent that the enforceability may be limited by applicable bankruptcy, reorganization, insolvency, moratorium
 or other Laws affecting the enforcement of creditors' rights generally.

1.4 With
 respect to each Seller that is a legal entity, the execution and consummation of this Agreement
 does not violate the articles of incorporation or constitutional documents of the Seller or the Company or any agreement,
 Laws or judgment to which the Seller or the Company respectively is a party or to which the Seller or the Company respectively is
 subject or bound.

1.5 There
 is no requirement for the Sellers to make any filing to or to obtain any approval from any Governmental Authority as a condition
 to consummating the transaction contemplated by this Agreement.

1.6 No
 Seller is involved in any legal or other proceedings, nor are such proceedings pending, threatened or reasonably likely to arise,
 which in any manner challenges or seeks to prevent, materially alter or materially delay the transactions contemplated in this Agreement.

1.7 No
 Seller is insolvent (*zahlungsunfähig*) or subject to any pending or threatened voluntary or involuntary dissolutions,
 reorganisations, debt moratoria, bankruptcy, debt collection or similar proceedings.

**2.** **Title to Shares** 

2.1 The
 Sellers have good and valid title to the Shares, free and clear of any Liens and the Shares are not subject to any pre-emptive right,
 right of first refusal, right of first offer or any similar right of a third party or other transfer restrictions (other than transfer
 restrictions provided for in the articles of association of the Company and under the shareholders' agreement related to the
 Company), and the Company is not party to any arrangement for sharing income.

2.2 The
 Sellers hold 100% of the Shares and each Seller is the legal and beneficial owner of the number of Shares as set out in Annex I.

2.3 Each
 Seller has the right and capacity to transfer and sell complete title to its Shares on the terms of this Agreement. Upon consummation
 of the transaction contemplated by this Agreement in accordance with the terms hereof, the Purchaser will receive good and valid
 title to the Shares, free and clear of any Liens.

**3.** **INITIAL CONSIDERATION SHARES** 

3.1 Each
 Seller is acquiring the Initial Consideration Shares for his or her own account for investment purposes only and not with a view
 to any public distribution thereof or with any intention of selling, distributing or otherwise disposing of the Initial Consideration
 Shares in a manner that would violate the registration requirements of the Securities Act of 1933, as amended (the "Securities
 Act"). Each Seller agrees that the Initial Consideration Shares may not be sold, transferred, offered for sale, pledged, hypothecated
 or otherwise disposed of without registration under the Securities Act and any applicable state securities laws, except pursuant
 to an exemption from such registration under the Securities Act and such laws. Each Seller is able to bear the economic risk of holding
 the Initial Consideration Shares for an indefinite period (including total loss of its investment), and has sufficient knowledge
 and experience in financial and business matters so as to be capable of evaluating the merits and risk of his, her or its investment.

3.2 Each
 Seller is an "accredited investor" within the meaning of Rule 501(a) under the Securities Act and each Seller is not
 subject to any of the "Bad Actor" disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act.
 Each Seller is not a U.S. Person as defined in Regulation S. If a Seller is not a U.S. Person, such Seller (i) acknowledges that
 the certificate(s) representing or evidencing the Initial Consideration Shares contains a customary restrictive legend restricting
 the offer, sale or transfer of any Initial Consideration Shares except in accordance with the provisions of Regulation S, pursuant
 to registration under the Securities Act, or pursuant to an available exemption from registration, (ii) agrees that all offers and
 sales by such Seller of Initial Consideration Shares shall be made pursuant to an effective registration statement under the Securities
 Act or pursuant to an exemption from, or a transaction not subject to the registration requirements of, the Securities Act, (iii)
 represents that the offer to purchase the Initial Consideration Shares was made to such Seller outside of the United States, and
 such Seller was, at the time of the offer and will be, at the time of the sale and is now, outside the United States, (iv) has not
 engaged in or directed any unsolicited offers to purchase Initial Consideration Shares in the United States, (v) is neither a U.S.
 Person nor a Distributor (as such terms are defined in Rule 902(k) and 902(d), respectively,
 of Regulation S), (vi) is purchasing the Initial Consideration Shares for its own account and not for the account or benefit
 of any U.S. Person, (vii) is the sole beneficial owner of the Initial Consideration Shares specified on signature pages hereto opposite
 his name and has not pre-arranged any sale with a Seller in the United States, and (ix) is familiar with and understands the terms
 and conditions and requirements contained in Regulation S, specifically, without limitation, such Seller (i) agrees not to engage
 in hedging transactions with regard to the Initial Consideration Shares unless in compliance with the Securities Act; and (ii) understands
 that the statutory basis for the exemption claimed for the sale of the Initial Consideration Shares would not be present if the sale,
 although in technical compliance with Regulation S, is part of a plan or scheme to evade the registration provisions of the Securities
 Act.

---

| | |
|:---|:---|
| 3.3 | Each Seller has had the opportunity to consult his, her or its own independent legal, tax, accounting and other advisors with respect to each Seller's rights, benefits, and obligations under this Agreement and the tax and other economic consequences to such Seller of the receipt or ownership of the Initial Equity Consideration, including the tax consequences under applicable laws and the possible effects of changes in such applicable laws. Each Seller is not relying on Purchaser or any of its affiliates or any of Purchaser's employees, agents, representatives or advisors with respect to the legal, tax, economic and related considerations of an investment in the Initial Equity Consideration. |
| 3.4 | Each Seller understands and agrees that the investment in the Initial Consideration Shares involves a high degree of risk and that no guarantees have been made or can be made with respect to the future value of the Initial Consideration Shares or the future profitability or success of Purchaser, the Company and their respective affiliates. |
| 3.5 | Each Seller acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits and schedules thereto) and the Company's filings with the Securities and Exchange Commission and has been afforded, (i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Initial Consideration Shares and the merits and risks of investing in the Initial Equity Consideration; (ii) access to information about the Company and its financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment. |
| 4. | Each Seller consents to the placement of a legend on any certificate or other document evidencing the Initial Consideration Shares that such securities have not been registered under the Securities Act or any state securities or "blue sky" laws and setting forth or referring to the restrictions on transferability and sale thereof contained in this Agreement. Each Seller is aware that the Purchaser will make a notation in its appropriate records with respect to the restrictions on the transferability of such Initial Equity Consideration. The legend to be placed on each certificate shall be in form substantially similar to the following: |
|  | THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR ANY STATE SECURITIES LAWS. THESE SECURITIES MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. |

---

**Annex 6.3**

**Business Representations and Warranties**

**Annex 6.3**

**Business Representations and Warranties**

**1.** **Compliance with Applicable Laws** 

1.1 The
 Company has at all times and in all material respects conducted its business and affairs in accordance with applicable Laws, including
 any orders or directions from any Governmental Authority. The Company has not received written notice from any Governmental Authority
 that it is in breach of any applicable Law and the Company is not in default of any Law, order, decree or judgment of any court or
 any Governmental Authority in any jurisdiction.

1.2 No
 Governmental Authority has required the Company to take or to omit any action (including in relation to any person acting for or
 on behalf of the Company) to rectify any violation or non-compliance with any Laws, and the Company has not received any written
 notice or is under any order or direction from any Governmental Authority regarding the same.

1.3 The
 Company is not the subject of any ongoing official investigation or inquiry or proceedings initiated by any Governmental Authority
 with regard to any actual or suspected violation or non-compliance with any Law nor do any circumstances or facts exist in relation
 to the Company (nor any person acting on behalf of the Company) and/or to the conduct of the business of the Company which are likely
 to give rise to any such investigation or inquiry or proceedings.

1.4 The
 Company has obtained all licences, permits, approvals and authorizations (public or private) or consents required under applicable
 Law to operate its business as currently conducted and all such licences, permits, approvals and authorizations are in full force
 and effect.

1.5 The
 Company has not applied for or received any investment grant, employment subsidy or other similar payment or allowance and no such
 grant, subsidy, payment or allowance paid or due to be paid to the Company is or may be liable (if already provided) to be refunded
 or (if application has been made), withheld or refused (in whole or in part) (including without limitation, in consequence of anything
 which the Company has done or omitted to do (or has agreed to do or omit to do) or for any other reason).

1.6 There
 are no contracts or obligations, agreements, arrangements or concerted practices involving the Company and no practices in which
 the Company is or has been engaged which are void, illegal, unenforceable, registrable or notifiable under or which contravene any
 competition, anti-trust, anti-monopoly or anti-cartel legislation or regulations anywhere in the world, nor has the Company received
 any threat or complaint or request for information or investigation in relation to or in connection with any such legislation or
 regulations. The Company is not subject to any order, judgment, decision or direction given by any court or governmental or regulatory
 authority in any jurisdiction, nor is it party to any undertaking or assurance given to any such court or authority, in relation
 to competition matters which are still in force.

**2.** **Financial Information** 

2.1 The
 data room folder accessible to the Buyer under <u>https://caligae.dealroom.net/#/documents/folder/543408</u> Folder 1 (specifically
 Index 1.1. and 1.7. contains true and complete copies of the following financial statements of the Company (**Financial Statements**):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. the
 audited balance sheet of the Company as of 31 December 2023 and the audited balance sheet of the Company as of 31 December 2024,
 and the related income statements, together with the notes thereto for the years then ended; and,

b. the
 unaudited interim balance sheet of the Company as of 30th June 2025 and the related income statement, for the 6 months then ended.

2.2 The
 Financial Statements are complete and correct and consistent with the books and records of the Company and have been prepared in
 accordance with applicable Law and have been prepared using the same bases, methods, principles and policies of accounting, valuation
 and depreciation. The Financial Statements give a true and fair view of the assets and liabilities, financial condition and earnings
 positions of the Company as for the times and for the periods referenced therein. Without limiting the foregoing, none of the assets
 recorded in the Financial Statements are overvalued and none of the liabilities are undervalued.

2.3 The
 Financial Statements disclose and make full provisions or reserves for all liabilities (or note in accordance with the accounting
 principles) and for all accrued, contingent, uncertain or disputed liabilities. The Company has no liabilities except for liabilities
 set forth in the Financial Statements (including its notes), as for the times and for the periods referenced therein.

2.4 The
 books of the accounts and all supporting books and records have been properly kept as required under the applicable legal, regulatory
 and accounting requirements and are up-to-date.

**3.** **Assets** 

3.1 The
 assets owned, leased or licensed by the Company include all of the tangible and intangible assets, properties and rights necessary
 to conduct the Activity of the Company as presently conducted and as currently proposed to be conducted.

3.2 The
 Company has good and marketable title to, or a valid right to use, all tangible and intangible assets, property and rights used by
 the Company or shown in the Financial Statements (except to the extent that assets have been disposed of in the Ordinary Course of
 Business), in each case free and clear of all Liens.

3.3 All
 assets of the Company are in good condition and repair and are useable in the Ordinary Course of Business and none of these assets
 require any repair or replacement except for maintenance in the Ordinary Course of Business.

3.4 None
 of the assets of the Company are held under any lease, security agreement, conditional sales contract or other title retention or
 security arrangement or is located other than on the premises of the Company.

---

| | |
|:---|:---|
| **4.** | **Products and Services** |
|  | The Company has not sold any products or rendered any services which fail to comply with any representations or warranties made by the Company or with any legal or regulatory Laws or technical specifications which the products and services purport to fulfil, and the Company has not received written notice of any material claim by any customer or third party in respect thereof that has not been fully provisioned or reserved in the Financial Statements. |
| **5.** | **No Real Property** |
|  | The Company does not own and has not owned since its incorporation any real property. |
| **6.** | **Tax Matters** |
| 6.1 | All Tax Returns, notices and computations required to be filed prior to Closing by or with respect to all Taxes, both direct and indirect, under any jurisdiction or any part thereof, payable or to be withheld or reimbursable by the Company have been filed in a timely manner. All such Tax Returns, notices and computations: |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. have
 been prepared in the manner required by the applicable Laws;

b. are
 true, correct and complete and are not subject of any material dispute nor are likely to become subject of any material dispute with
 Tax Authorities; and

c. accurately
 reflect the liability for all Taxes, both direct and indirect, under any jurisdiction or any part thereof, of the Company.

6.2 The
 Swiss tax assessments of the Company with respect to cantonal and federal income taxes are final up to and including the financial
 year 2023, whereas the tax assessments for the year 2024 are pending.

6.3 All
 Taxes (whether or not shown on any Tax Return) relating to a tax period ending on (and including) the Closing Date have been timely
 and fully paid, withheld or collected when due, or, to the extent not due prior to the Closing Date, fully provisioned for as Real
 Financial Debt. Since 1 January 2025 Taxes have only accrued in the Ordinary Course of Business. Without limiting the generality
 of the foregoing, the Company has deducted, withheld and timely paid to the appropriate governmental or regulatory authority all
 Taxes or social security contributions in connection with amounts paid or owing to any employee, independent contractor, creditor,
 shareholder or other third party.

6.4 The
 Company has not been involved in any transactions with any of its shareholders, directors, employees or any other Related Parties,
 which has given or may give rise to a liability for Taxes, including any constructive or hidden dividends, other than Taxes arising
 from normal business activities or transactions entered into during the Ordinary Course of Business.

6.5 No
 claim has been made by a Governmental Authority in a jurisdiction where the Company does not file Tax Returns that the Company is
 or may be subject to taxation by that jurisdiction, and there is no basis for any such claim to be made.

**7.** **Material Contracts** 

7.1 The
 data room folder accessible to the Buyer under <u>https **://caligae.dealroom.net/#/documents/folder/543408 Folder 1.5**</u> , 2.2 and 2.3.12 contains all material contracts, whether entered into in writing or orally, of the Companies
 with any party regarding (the contracts contained therein collectively the  ***Material Contracts***):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. joint
 venture agreements, co-operation, strategic alliances, joint development, IP or software-development contracts and similar agreements;

b. consultancy,
 service or IT agreements with agreed payments exceeding USD 5,000 per annum;

c. rental
 and lease agreements regarding premises used by the Company;

d. loans
 or other credit agreements entered into as a lender or borrower;

e. guarantees,
 suretyships, assumption of debts, comfort letters or similar legal instruments of any kind issued by the Company;

f. license
 agreements entered into as a licensor or licensee with regard to or relating of any of the Company's IP Rights, including any
 licenses relating to Licensed IP- Rights **,** and/or any other contracts with third parties or Related Parties regarding the development
 or use of IP-Rights;

g. agreements
 with customers, suppliers, franchise partners, distributors (commercial agents) and sponsorship agreements in each case with an aggregate
 contract value exceeding USD 5,000;

h. any
 other agreement, which provides for any restrictive impact on competition;

i. any
 other agreement which requires annual payments of USD 5,000 or more in the individual case;

j. any
 material transaction, arrangement or understanding between the Company and any Related Party;

k. any
 other agreement or obligation which has been entered into or incurred outside the Ordinary Course of Business or which otherwise
 are of material relevance for the Activity of the Company.

l. agreements
 or arrangements regarding confidentiality and non- disclosure;

m. management
 service, consulting, maintenance or any other similar agreements, contracts or commitments (including any employee lease or outsourcing arrangements);

7.2 All
 Material Contracts are valid, binding and enforceable and have been entered into at an arms' length basis. None of the Material
 Contracts has been terminated or is about to be terminated, in particular, the Company has not given or received any notice of ordinary
 or extraordinary termination, or written request or threat for modification of any Material Contract.

7.3 The
 Company has complied with its respective material obligations under all Material Contracts and has not received any notice of breach
 by a counterparty. To Majority Seller's best knowledge, all contractual counterparties to a Material Contract have complied
 with their obligations thereunder. No counterparty under a Material Contract has a right to terminate, amend or otherwise modify
 a Material Contact in connection with this Agreement or its consummation.

**8.** **IP-Rights** 

8.1 The
 data room folder accessible to the Buyer under <u>https://caligae.dealroom.net/#/documents/folder/543408</u> (Index 2.4.7.) contains
 a complete and correct list of all registered or applied-for IP-Rights owned by the Company (the  ***Owned IP-Rights***).
 None of the Owned IP-Rights is subject to any Lien and the Company is the sole and exclusive legal and beneficial owner of the Owned
 IP-Rights.

8.2 The
 data room folder accessible to the Buyer under  **<u>https://caligae.dealroom.net/#/documents/folder/543408</u> (Folder 2.4.)** contains
 all licences, agreements, authorisations and permissions pursuant to which the Company (i) uses, exploits or holds (or is permitted
 to use, exploit or hold) any Intellectual Property of any third party or (ii) authorises or permits the use of any Intellectual Property
 of the Company (the  ***Licensed IP-Rights***).

8.3 The
 Company holds, or has the right to use, all IP-Rights that are required to carry on the Company's Activity as carried on as
 at the date of this Agreement and in the twenty- two months immediately prior to the date of this Agreement.

8.4 All
 IP-Rights are (or, where appropriate in the case of pending applications, will be):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. in
 force, valid and binding and have nothing has been done or not been done as a result of which any of them has ceased to be valid;

b. not
 being infringed or challenged or opposed by any Person in any manner and there is no reason to anticipate such infringement, challenge
 or opposition;

c. in
 case of IP-Rights which are registered or which are subject of applications for registration, are validly registered or applied for
 in the name of the Company, have been properly used to maintain their validity, all registration or renewal fees which are due have
 been paid, and all steps which are required for their registration, maintenance and protection have been taken; and

d. in
 case of IP-Rights related to software developed for use with the Company's products or
 services, are fully and solely owned by the Company and the Company has the right to use, make derivative works or other modifications,
 license, sub- licence, sell or distribute such software without any restrictions.

8.5 The
 business of the Company does not infringe, and has not infringed in the past, any intellectual property rights of any third party
 (or would not do so if the same was valid). Without prejudice to the foregoing, the Company has not (except as consistent with the
 Ordinary Course of Business):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. granted
 any licenses in respect of any IP-Rights required by the business of the Company;

b. knowingly
 permitted or caused, in connection with the business of the Company, any infringement of intellectual
 property rights owned by a third party without taking action in relation to that infringement and remedying it; or

c. entered
 into any Lien in relation to the IP-Rights required by the business of the Company.

8.6 The
 Company has taken all measures to maintain the confidentiality of its trade secrets and know-how.

8.7 As
 to the Licensed IP-Rights or know-how licensed to the Company, all royalties due thereunder have been fully and timely paid.

8.8 Each
 person (including current and former employees and officers of the Company and freelancers, independent contractors, consultants)
 who create or contribute to any portion of, or otherwise would have rights in or to, the IP-Rights of the Company has executed a
 written agreement (including in wet ink (where required by applicable law to be enforceable)) with the Company that validly and irrevocably
 assign to the Company all of their rights in and to such IP-Rights, confidentiality and proprietary information and assignment of
 inventions and/or copyrights No person (including current and former employees and officers of the Company and freelancers, independent
 contractors, consultants) has (i) excluded any works or inventions made prior to his or her employment with the Company from his
 or her assignment of inventions, or (ii) failed to affirmatively indicate in such agreement that no such works or inventions made
 prior to his or her employment with the Company exist. The Majority Sellers are not aware that any person is in violation thereof.

8.9 The
Company has not used or distributed any software owned by the Company (**Proprietary Software**) in conjunction with any Open Source
Software in a manner that may subject to such Proprietary Software, in whole or in part, to all or part of the license obligations of
an Open Source Software of grants, or purports to grant, to any third party, any rights or immunities pursuant to any IP-Right. No Proprietary
Software is subject to any "copyleft" or other obligation or condition (including any obligation or condition under any "open
source" license) that (i) requires or conditions (or purports to require or condition) the use of such Proprietary Software, the
applicable Open Source Software or a portion of either of the foregoing on, (A) the disclosure, licensing, or distribution of any source
code for any portion of such Proprietary Software or (B) the granting to any third party the right to make derivative works or other
modifications to such Proprietary Software or portions thereof or (ii) otherwise imposes any limitation, restriction, or condition on
the right or ability of the Company to use, distribute or charge for any Proprietary Software. No material portion of the source code
of any Proprietary Software has been published, placed in escrow, and no licenses or rights have been granted to any third party to distribute,
or to otherwise use the source code of, any of the Proprietary Software.

**9.** **Information Technology** 

9.1 The
 Business IT is legally and beneficially owned by or validly licensed, lease or supplied by third parties to the Company. The Business
 IT is in good working order in all material respects and free of malware. The present capacity and performance of the Business IT
 is sufficient to satisfy the current and reasonably projected business requirements (including requirements as to data volumes) of
 the Company.

9.2 The
 Company does not develop or distribute, nor has developed or distributed any software licensed, provided, or distributed under any
 open source license, including any license meeting the Open Source Definition (as promulgated by the Open Source Initiative) or the
 Free Software Definition (as promulgated by the Free Software Foundation) or any software that contains or is derived from any such
 software (**Open Source Software**) in any matter that would require any source code of the software included in the IP-Rights
 disclosed, licensed for free, publicly distributed, attributed to any person or dedicated to the public. The Company is in compliance
 in all material respects with all terms and conditions of all relevant licenses (including all requirements relating to notices and
 making source code available to third parties) for all Open Source Software used in the Company's business.

9.3 In
 the 24 months before the date of this Agreement, the Business IT has not failed to any material extent and the data that they process
 has not been corrupted or compromised. The Company has implemented reasonable measures designed to prevent the Business IT from being
 affected by, and the Business IT is free from, viruses, bugs or other things that might distort their proper functioning, permit
 unauthorized access or disable them without the consent of the user.

9.4 The
 Company (1) has implemented, maintains, and complies with commercially reasonable written information security, business continuity
 and backup and disaster recovery plans and procedures that are consistent with industry practices, and (2) has taken commercially
 reasonable steps to assess and test such plans and procedures on no less than an annual basis, and such plans and procedures have
 been proven effective upon such testing in all material respects.

9.5 No
 action (including the payment of any sum, or any increased sum, other than normal software licence fees) will be necessary following
 Closing and as a result of the transaction in order to enable the Business IT to continue to be used by the Company to the same extent
 and in the same manner as they have been used up to and including the date of this Agreement.

**10.** **Social Security Matters** 

10.1 The
 Company has an affiliation agreement for occupational pension provision with asga pensionskasse,
 Rosenbergstrasse 16, Postfach, 9001 St. Gallen, with an end term of 31 December 2019. There are no (other) individual pension commitments
 of the Company towards employees or former employees under which the Company has any pension obligations.

10.2 The
 Company is in compliance with all applicable pension and social security Laws.

10.3 All
 social security, pension fund, benefit plan or similar payments due by the Company in favour of the employees under the applicable
 Laws or any benefit plans relating to a period ending on (and including) the Closing Date have been timely and fully paid, withheld
 or collected when due, or, to the extent not due prior to the Closing Date, fully provisioned for as Real Financial Debt.

10.4 The
 benefit plans of the Company do not have an accumulated funding deficiency pursuant to the applicable Laws.

10.5 The
 benefit plans have been established and administered in accordance with its terms and in compliance with the applicable Laws.

10.6 The
 Company has prepared and filed all declarations, returns and reports required to be filed with respect to social security contributions
 or pension schemes in the manner required by the applicable Laws and these are true, correct and complete and are not subject of
 any material dispute nor are likely to become subject of any material dispute with any competent Governmental Authorities.

**11.** **Employment Matters** 

11.1 The
 data room folder accessible to the Buyer under  **<u>https://caligae.dealroom.net/#/documents/folder/543408</u> (Index 2.3.12.18.)** is a correct and complete list of all directors, officers and employees of the Company with their salaries
 and remuneration, including variable compensation entitlements and other monetary fringe benefits.
 There are no salary increases resolved but not yet implemented.

11.2 The
 Company complies with all legal, contractual, regulatory, collective bargaining agreements, social security, pension plans and other
 obligations relating to current and former employees, contractors and consultants. Without limiting the foregoing, the Company has
 paid all compensation that has become due and payable and has made sufficient provisions for accrued and accruing compensation, including
 for severance obligations, deferred compensation, bonus and similar payments, overtime work or accrued vacation in the Financial
 Statements for the period ended December 31, 2024 or provisioned for as Real Financial Debt.

11.3 The
 Company has not set up any written or oral share incentive schemes, share option schemes or other equity linked incentive schemes
 for the benefit of any of its directors, officers and employees.

11.4 The
 Company has no obligation to make any severance, change-of-control or transaction bonus payment, or any payment of compensation for
 loss of office, employment or redundancy to any present or former director, officer or employee as a direct consequence of the transaction
 contemplated by this Agreement.

11.5 No
 employee has given notice of termination of his/her employment or has indicated an intention to terminate his/her employment due
 to the transaction contemplated by this Agreement or for any other reason.

11.6 All
 necessary work permits or other authorizations required by the applicable Laws for the employment of directors and/or employees of
 the Company have been obtained and are in full effect.

11.7 There
 are no allegations, complaints or claims of sexual harassment made against any directors, officers or employees of the Company and
 to the best knowledge of the Sellers, there are no facts or circumstances likely to give rise to any such allegations, complaints
 or claims.

11.8 There
 are no current pending or threatened disputes with any employee, Governmental Authorities, self-regulatory authorities, works councils
 or other employee representatives. No mass dismissals have been announced or are being planned.

**12.** **Insurance** 

12.1 The
 data room folder accessible to the Buyer under  **<u>https://caligae.dealroom.net/#/documents/folder/543408</u> (Index 2.5.1.)** contains a correct and complete list of all insurance policies carried by, or covering, the Company with respect
 to the Company's business.

12.2 Such
 insurance policies are in full force and effect and all premiums due thereon have been paid and the Company is in no default thereunder.
 The Company has neither received any notice of cancellation or intent to cancel or intent to increase premiums with respect to such
 insurance policies, nor, to the knowledge of Sellers, is there any basis for any such action.

12.3 All
 such insurance policies contain coverages that are adequate and prudent in light of the risks inherent in the Company's business.

12.4 There
 are no pending claims, (ii) and there were no claims in the past 3 (three) years with any insurance company, and (iii) within the
 past 3 (three) years there was no denied coverage by any insurance company.

**13.** **Litigation and Investigations** 

13.1 Other
 than as disclosed with regard to the Santoni case and debt enforcement proceedings initiated by Oliver Schäfer against the Company,
 there are and there were in the past 3 (three) years prior to the Closing Date no Proceedings, claims or Orders pending or threatened
 against the Company or any Persons for whose acts the Company is responsible (by applicable laws or contract), or against any of
 the Sellers or to which any of the Sellers is a party with respect to the Activity of the Company, before any court, arbitral tribunal
 or before any Governmental Authority, nor is there to the best knowledge of the Majority Sellers any basis for any such Proceedings,
 claims or Orders.

13.2 The
 Company is neither subject to any Order of any Governmental Authority, nor has the Company received any written opinion or memorandum
 or legal advice from a legal counsel retained by the Company or any of the Sellers to the effect that the Company is exposed, from
 a legal standpoint, to any Liabilities which may be material.

**14.** **Data Protection and Data Security** 

14.1 The
 Company has complied in all material respect with all legal and other regulations applicable to the Company and to its business relating
 to the collection, processing, compilation, use, storage, backup, disclosure, access, transfer and any other handling with personal
 data according to the Swiss Act on Data Protection, its implementing ordinances (*Ausführungsverordnungen*) and the Regulation
 (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to
 the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection
 Regulation, GDPR) (**Data Protection Regulations**).

14.2 Neither
 the Company nor the Sellers have ever received a communication or notification from any authority or court of non-compliance with
 Data Protection Regulations or are aware of violations of Data Protection Regulations.

14.3 The
 Company has during the last five years not:

a. suffered
 any material breach of security leading to the accidental or unlawful destruction, loss, alteration, unauthorised disclosure of,
 or access to any personal data controlled by it;

b. received
 any written notice or allegation from any data protection regulator in any other jurisdiction, or a data controller or a data subject,
 alleging non- compliance with any Data Protection Regulations (including data protection principles); or

c. received
 a written claim, written complaint or written correspondence from a data subject or any other person claiming a right to compensation.

**15.** **Absence of Changes** 

15.1 Since
 January 1st, 2025:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. the
 Company's business has been carried on in the Ordinary Course of Business;

b. no
 liabilities have been incurred other than those arising from the Ordinary Course of Business; and

c. no
 Material Adverse Change has occurred.

15.2 Since
 January 1st, 2025, with respect to the business of the Company, the Company has not:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. engaged
 in (i) any merger or consolidation with any other Person; (ii) any acquisition (whether by merger, consolidation or acquisition of
 shares or assets) of any other Person; or (iii) any acquisition of any material assets from any other Person (except for purchases
 of supplies in the Ordinary Course of Business);

b. sold,
 assigned, transferred, conveyed, leased, distributed or otherwise disposed of any of their assets and properties (whether tangible
 or intangible), whether or not reflected on the books of the Company, except for sales of inventory for fair consideration in the
 Ordinary Course of Business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. formed,
 entered into, varied, terminated or withdrawn from, any material partnership, consortium, joint venture or other association;

d. instituted
 any change in its methods of accounting, or accelerated the collection of accounts receivable or delayed the payment of accounts
 payable of more than CHF 75'000;

e. issued
 or cancelled shares of the Company, or granted any rights to acquire such new shares (or any derivatives thereof including options,
 conversion rights, etc.);

f. entered,
 into, increased or extended any liability under any guarantee or indemnity in excess of CHF 10,000 per item other than in the Ordinary
 Course of Business or incurred or became subject to, or agreed to incur or become subject to, any liability except (i) normal trade
 or business obligations incurred in the Ordinary Course of Business; and (ii) obligations under Material Contracts in effect on the
 date of this Agreement;

g. borrowed
 any money or incurred any indebtedness or other liability against a third party in excess of CHF 10,000 per item other than in the
 Ordinary Course of Business;

h. initiated,
 discontinued or settled any litigation, arbitration, administrative or any similar proceedings where the amount claimed together
 with any costs incurred or likely to be incurred exceeds CHF 10,000 per item;

i. agreed
 or committed to do any actions set forth in the foregoing paragraphs a. through h. of this section.

---

| | |
|:---|:---|
| **16.** | **Stock options plan** |
|  | All options granted under any Company's current or previups employee participation program, including those designated as 'non-forfeitable', have lapsed and are no longer exercisable, as the applicable exercise periods have expired and all vesting and employment-related conditions have ceased to exist. No person has any right, whether legal, contractual or equitable, to exercise any option, to acquire shares, or to receive any compensation in connection with any former option entitlement. |
| **17.** | **Broker Fees** |
|  | Other than as disclosed in connection with the agreement between the Company, the Majority Sellers and Corum Group International S.à.r.l. as M&A advisor, neither the Company, nor the Sellers have employed any broker, finder or agent or other intermediary in connection with the transactions contemplated by this Agreement to whom the Company would be obligated to pay a broker's, finder's or similar fee or commission. |

---

**18.** **Corporate Existence** 

18.1 The
 Company is duly incorporated and organized and validly existing under the Laws of Switzerland, is in good standing and has the full
 corporate power and authority to own, hold or use its assets and properties and to conduct the Activity as the same is presently
 being conducted.

18.2 The
 Shares represent the entire issued and outstanding share capital of the Company. The Shares of the Company are validly issued and
 fully paid and non-assessable. there are no outstanding options, warrants, calls, rights or commitments, or any other agreements
 of any character relating to the sale, issuance or voting of, or the granting of rights to acquire, any of the Shares or any other
 securities of the Company.

18.3 Since
 its incorporation until and including the Closing Date, the Company has not issued any physical share certificates.

18.4 The
 share register, share transfer records and other shareholder records for the Company are complete and correct and have been maintained
 in accordance with good business practices and the applicable legal requirements.

18.5 There
 exists no authorization, obligation or arrangement (present or future, absolute, contingent or otherwise) of the Company or any of
 the Sellers to issue or sell shares in the Company to any Person. No further capital other than the conditional capital set forth
 in the Company's articles of association of CHF 17'805.00 (whether in the form of authorized capital or a capital band),
 shares, or other equity instruments in the Company have been created or issued or will be issued on or before the Closing Date.

18.6 The
 electronic excerpt from the Commercial Register regarding the Company dated March 13, 2025 is true, correct and complete. Only the
 persons registered in the Commercial Register are authorized to represent the Company.

18.7 The
 articles of association of the Company have been disclosed in in the course of the Due Diligence Process prior to the Closing Date
 and are true, correct and complete. The Company is in no violation of its articles of association (or other constitutive documents)
 or bylaws (or other governing documents).

18.8 The
 Company does not have any subsidiaries (other than NÚMERO DE CALZADO, S.L., registered within the Commercial Register of Barcelona
 registered with Tax I.D. number B66422882), and does not hold any shares, interests or equity in any other Person and does not have
 any branches, agencies or permanent establishments.

18.9 The
 Company is not insolvent (*zahlungsunfähig*), but is currently over-indebted, nor subject to any pending or threatened
 voluntary or involuntary dissolutions, reorganisations, debt moratoria, bankruptcy, debt collection or similar proceedings.

---

| | |
|:---|:---|
| **19.** | **No Breach due to Transaction** |
|  | The execution, delivery and performance of this Agreement and the Transaction Documents and the consummation of the transaction contemplated by this Agreement will not: |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. violate
 or conflict in any respect with any provision of the articles of association (or other constitutive documents) or by-laws (or other
 governing documents) of the Sellers or the Company;

b. violate
 or conflict with or result in a breach of or default under any provision of any Law;

c. breach,
 violate or constitute a default under or an event which would give rise to any right of termination or cancellation, in accordance
 with the express terms of any material agreement to which the Company is a party;

d. require
 from the Sellers any notice to, declaration or filing with, or consent or approval of, any Governmental Authority or other third
 party; or

e. violate
 or conflict with in any way, or result in a violation of, or constitute a default (whether after the giving of notice, lapse of time
 or both) under, any provision of any Law or any restriction imposed by, any court or Governmental Authority.

---

| | |
|:---|:---|
| **20.** | **Disclosure** |
|  | All information provided by or on behalf of the Company by the Sellers or on their behalf by any of their advisors in connection with the transactions contemplated by this Agreement is complete and accurate in all material respects and the Sellers have disclosed all facts of objective significance relating to the assets, business, operations, financial conditions, earnings or prospects of the Company. |

---

**Annex 6.15**

**Claim procedure**

In the event of a claim for any Loss arising from the events listed in clauses 6.2, 6.3 and 6.4, the following provisions shall apply:

---

| | |
|:---|:---|
| **1.** | **Direct Claim** |
| The procedure set out below must be followed for any claim which does not relate to a Third**-**Party Claim (as defined below) (a ***Direct Claim***): | The procedure set out below must be followed for any claim which does not relate to a Third**-**Party Claim (as defined below) (a ***Direct Claim***): |

---

---

| | |
|:---|:---|
| (i) | When the Purchaser becomes aware of any circumstance that might give rise to a Loss, and no later than forty-five (45) Business Days from that date, shall give notice to the Sellers' Representative of any Direct Claim (a ***Notice of Direct Claim***). |
| (ii) | The Notice of Direct Claim shall be made in writing and shall: (i) summarily describe in reasonable terms the circumstances and facts, to the extent then known to the Purchaser, that might give rise to the Loss; (ii) indicate the nature and where reasonably practicable the amounts of the Loss suffered and, where such amount is not possible to determine, the current initial estimate of such amount of the Loss that could be suffered by the Company and/or the Purchaser; (iii) mention (without detailed legal reasoning) the grounds on which the Purchaser understands that such facts or circumstances entail an indemnifiable Loss, and mention the particular provisions in this Agreement under which the Sellers' liability is applicable.. |
|  | Failure by the Purchaser to comply with the time and formal requirements contained in the above shall not relieve the Sellers from liability for the alleged Loss, but the Sellers shall not be liable for the Loss (or increased Loss) caused by such failure. |
| (iii) | Within fifteen (15) Business Days from receipt of the Notice of Direct Claim, the Sellers' Representative must notify the Purchaser of (a) their acceptance of the Direct Claim and their obligation to pay the amount claimed by the Purchaser; or (b) their total or partial rejection of the Direct Claim and payment of its amount. If the Sellers' Representative fails to notify the Purchaser of their response within that term, it will be understood that they have rejected the Direct Claim and the provisions of the paragraph (v) below will apply. |
| (iv) | If the Sellers' Representative accepts the Direct Claim, the amount of Losses stated in the Notice of Direct Claim shall become final and binding, and the Sellers shall pay such amount to the Purchaser and/or the Company within ten (10) Business Days from the date in which the term to respond to the Notice of Direct Claim elapsed. |
| (v) | If (a) the Sellers' Representative rejects the Notice of Direct Claim, or (b) the term to respond to the Notice of Direct Claim has elapsed without the Purchaser having received any response from the Sellers, the Purchaser will be entitled to start the dispute resolution procedure provided for in section 3 below, for the issues and amounts rejected by the Sellers' Representative. If the dispute resolution procedure is not initiated by the Purchaser within sixty (60) Business Days following the end of the term to respond to the Notice of Direct Claim, the Purchaser will be deemed to have abandoned the relevant Direct Claim and will be obliged to initiate again the procedure described in section 1.1 of this Annex. |

---

**2.** **Third-Party Claim** 

If the claim is based on a Loss that may arise from a claim made by a third party, whether a private entity or a Governmental Authority, against the Purchaser and/or the Company (a ***Third-Party Claim***), the following procedure must be followed:

---

| | |
|:---|:---|
| (i) | When the Purchaser duly receives notice of a Third-Party Claim that might give rise to a Loss, will give notice to the Sellers' Representative to that effect and claim indemnity (a ***Notice of Third-Party Claim***), within the shortest of the following two (2) periods: (a) within thirty (30) Business Days after receipt of the Third-Party Claim; or, if any (b) no later than the end of the first one-third of the statutory period for responding to the Third-Party Claim. |
| (ii) | The Notice of Third-Party Claim shall be made in writing and include (i) the summons, complaint, pleading or other document(s) served on the Purchaser and/or the Company in connection with the Third-Party Claim; (ii) the same information as applicable for a Notice of Direct Claim as stated above; and (iii) such other documentation on the nature, grounds and background of the Third-Party Claim as may be reasonably possible within the timeframe for serving the Notice of Third-Party Claim. |
|  | Failure by the Purchaser to comply with the time and formal requirements contained in the above shall not relieve the Sellers from liability for the alleged Loss, but the Sellers shall not be liable for the Loss (or increased Loss) caused by such failure. |
| (iii) | The Sellers' Representative shall notify the Purchaser whether: (a) they reject that a Loss may eventually result from the Third-Party Claim; or (b) if they accept that a Damage may eventually result from the Third-Party Claim, and shall send such notification within the shorter of the following two (2) periods: (a) within fifteen (15) Business Days after receipt of the Notice of Third-Party Claim; or, if any (b) no later than the date on which the second one-third of the statutory period for responding to the Third-Party Claim expires. If the Sellers' Representative fails to notify the Purchaser of its response within that term, it will be understood that they have rejected the indemnification obligation derived from the Third-Party Claim. |
| (iv) | If the Sellers' Representative refuses their indemnification obligation, the dispute between the Sellers' Representative and the Purchaser shall be resolved pursuant to the provisions provided for in section 3 below. In this case, the Purchaser, acting in good faith, will be entitled to bring any defense it may consider appropriate against the Third-Party Claim, provided that: |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. The
 Purchaser shall conduct the defense in good faith with a view to minimizing the potential liability of the Sellers in connection
 with the Third-Party Claim and, to that end, shall be assisted by a legal counsel if reasonably required under the circumstances
 and, in general, take all legally and commercially reasonable measures for an adequate defense against the Third-Party Claim.

b. The
 Sellers, whether directly or through the advisors appointed at its discretion, will be entitled, at their own costs and expense,
 to all information on the progress of the Third- Party Claim and have at its own cost and expense reasonable access to the information
 and documents relating to it.

(v) If
 the Sellers' Representative acknowledges that the Third-Party Claim might give rise to a Loss, the Sellers' Representative
 will include in its response: (a) instructions to the Purchaser for total or partial opposition, setting out a specific defense,
 or for accepting the Third-Party Claim, or, alternatively; (b) notify that the Sellers assume the defense against the Third-Party
 Claim, accepting liability for any Loss that might be caused to the Purchaser under such Third-Party Claim.
For these purposes:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. In
 the case of (v) (a) above, the Sellers will pay the amount of the Loss to the Purchaser and/or the Company within twenty (20) Business
 Days since the date in which the payment of the relevant Loss to the third-party claimant is to be made.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. In
 the case of (v) (b) above, the Sellers will be entitled to bring the defense that they consider most appropriate (including conducting
 and leading the discussions and formalities with the competent Governmental Authorities) against the Third-Party Claim, contesting,
 reaching a court-mediated or out-of-court settlement or accepting the Third- Party Claim. The Sellers will be liable for the Losses
 arising as a result of the Third- Party Claim and will have to pay the amount to the Purchaser and/or the Company within the earlier
 of twenty (20) Business Days since the date payment to the third-party claimant is to be made or within the deadlines set by a competent
 Governmental Authorities. The Purchaser, whether directly or through the advisers appointed at the Sellers' discretion, will
 be entitled to request information on the progress of the Third- Party Claim and have, at its own cost and expense, free access to
 all the information and documents relating to that Third-Party Claim.

(vi) Notwithstanding
 the foregoing, (a) settlement or compromise in relation to the Third-Party Claim must have the express written consent of the Purchaser,
 which may not be unreasonably withheld; and (b) where the claim would, in the opinion of the Purchaser, have or result in a material
 adverse effect on the course of the Company's Activity because it is a claim that may affect the rights and obligations arising
 under relevant contracts, collective labour disputes or claims that may affect the Company's brands, image or reputation, the
 Purchaser may, at any time, assume the defense against the Third-Party Claim. In this case, the Purchaser shall provide reasonable
 evidence to the Sellers of the grounds for such assumption. In any event, the Sellers, themselves or through advisors appointed by
 the Sellers, shall have reasonable access to the information and documentation relating to the claim in question and the Purchaser
 shall take into consideration the guidance of the Sellers.

(vii) In
 cases where the Purchaser assumes the defense, if and to the extent that the Purchaser makes a decision involving a settlement, compromise
 or a decision not to continue the defense or not to take legal action to that effect, the Purchaser shall inform the Sellers'
 Representative (the  ***Defense Completion Notice***) who, within fifteen (15) Business Days of receipt of the Defense Completion
 Notice, shall advise the Purchaser whether: (a) the Sellers' Representative accepts the Purchaser's decision (in which
 case the liability procedure set out in this Annex shall be deployed in the ordinary way); or (b) the Sellers' Representative
 disagrees with the decision on the grounds that it prejudices their interests by failing to raise a defense —and thereby giving
 rise to Losses— in a matter in which they consider that the Company has not engaged in any wrongdoing and their intention to
 appoint an Independent Expert to determine whether this was indeed the case (the  ***Notice of Disagreement with the Defense Completion Notice***)

(viii) Once
 the Notice of Disagreement with the Defense Completion Notice has been communicated, the Parties shall have fifteen (15) Business
 Days to appoint an Independent Expert, and the report submitted by the Independent Expert shall be equally binding on the Parties
 (in case the issue is a legal and not an economic opinion, the Parties agree that the legal division of the Independent Expert shall
 issue its report, which shall consist of a legal opinion on the disputed issue).

---

| | |
|:---|:---|
| (ix) | In the event that the Independent Expert determines that there would have been (a) standing to prove that no wrongful action has been taken to justify the Third-Party Claim; or (b) that the liability should have been less than that ultimately assumed, there shall be no indemnification obligation on the part of the Sellers, or the indemnification shall only be on the amount indicated by the Independent Expert, respectively, and in addition the Purchaser shall bear the expenses of the Independent Expert. |
|  | On the other hand, in the event that the Independent Expert determines that the facts of the case are such that there would have been a liability equal to or greater than that ultimately assumed, the Sellers shall bear in full the actual Loss suffered by the Company and/or the Purchaser, and the expenses of the Independent Expert shall be borne in full by the Sellers. |
| (x) | In any of the above cases, the Purchaser will provide the information the Sellers need to exercise their right to defense as provided for in this section. In addition, the Purchaser shall, and shall use its best efforts to cause the Company to cooperate as necessary, which includes granting powers of attorney or executing other instruments for representation by lawyers or other representatives appointed at the Sellers' discretion. |
| **3.** | **Dispute resolution** |

---

In the circumstances where the Sellers have set out its objection to a Direct Claim or a Third-Party Claim, if that objection is not resolved with an agreement promptly and, in any event, no later than sixty (60) Business Days, the Purchaser will be entitled to initiate proceedings against the Sellers under the jurisdiction as provided for in clause 14.9 of the Agreement; for avoidance of doubt, it being agreed and understood that Claims of the Purchaser under this Agreement can be brought against the Sellers and are not time barred or forfeit as long as the procedure under this this Annex are ongoing and/or the deadlines and periods set forth in this Annex have not lapsed. In the event the Sellers' Representative and the Purchaser reach an agreement within the aforementioned period with regards to a Direct Claim, the Sellers shall pay the corresponding amount of Losses to the Purchaser or the Company within fifteen (15) Business Days from the date in which the Sellers and the Purchaser reach an agreement.

The complaint procedure provided for in this Annex is a prerequisite for the Purchaser's actions under the Agreement. Consequently, failure to comply with the claim procedure provided for herein shall preclude the Purchaser from initiating the dispute resolution procedure provided for in clause 14.9 of the Agreement.

## Exhibit 10.2

**Exhibit 10.2**

 **Certain confidential information contained in this document, marked by brackets and asterisk ([\*\*\*]), has been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K, because the Company customarily and actually treats such information as private or confidential and the omitted information is not material.**

**LOCK-UP AGREEMENT**

My Size Inc.

HaNegev 4, POB 1026, Airport City, Israel, 701000

Ladies and Gentlemen:

The undersigned signatory of this lock-up agreement (this "**Lock-Up Agreement**") understands that My Size Inc., a Delaware corporation ("**My Size**") has entered into a Share Purchase Agreement, dated September 8, 2025 (as the same may be amended from time to time, the "**Share Purchase Agreement**") with Timo Steitz, Swiss citizen, ID No. [\*\*\*] ("**T. Steitz**"), Willhelm Steitz, Swiss citizen, ID No. [\*\*\*] ("**W. Steitz**"), and Ettore Weilenmann, Swiss citizen, ID No. [\*\*\*] ("**Weilenmann**") (each a "**Seller**" and collectively the "**Sellers**") which provides, among other things, for the acquisition of ShoeSize.Me AG, a corporation duly constituted under the laws of Switzerland and registered within the Commercial Register of the canton of Solothurn under number [\*\*\*] ("**SZM**") in exchange, *inter alia*, for shares of common stock of My Size ("**My Size Common Stock**") upon the terms and subject to the conditions set forth in the Share Purchase Agreement. Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Share Purchase Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. As a material inducement to each of the Parties having entered into the Share Purchase Agreement, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the undersigned hereby irrevocably agrees that, subject to the exceptions set forth herein, without the prior written consent of My Size, the undersigned will not:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) until
 the earlier of 6 months after the latest issuance of any Initial Consideration Shares or
 other shares to any Seller or successor thereof, (a "**Restricted Period** ")
 as applicable:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. offer,
 pledge, sell, contract to sell, sell any option, warrant or contract to purchase, purchase
 any option, warrant or contract to sell, grant any option, right or warrant to purchase,
 or otherwise transfer or dispose of, directly or indirectly, any shares of My Size Common
 Stock or any securities convertible into or exercisable or exchangeable for My Size Common
 Stock in each case, that are currently or hereafter owned of record or beneficially (including
 holding as a custodian) by the undersigned (collectively, the "**Undersigned's Shares** "), or publicly disclose the intention to make any such offer, sale, pledge,
 grant, transfer or disposition; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii. enter
 into any swap, short sale, hedge or other agreement that transfers, in whole or in part,
 any of the economic consequences of ownership of the Undersigned's Shares regardless
 of whether any such transaction described in clause (i) above or this clause (ii) is to be
 settled by delivery of My Size Common Stock or such other securities, in cash or otherwise.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) during
 the 3-month period following a Restricted Period, on any given trading day, sell, dispose
 or otherwise transfer shares of My Size Common Stock which represent more than the average
 daily trading volume of My Size Common Stock for the rolling 30 trading day period prior
 to the date on which the undersigned executes a trade of My Size Common Stock without the
 prior written consent of My Size (which My Size shall be permitted to withhold at its sole
 discretion).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. The restrictions and obligations contemplated by this Lock-Up Agreement shall not apply to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) transfers
 of the Undersigned's Shares:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. if
 the undersigned is a <u>natural person</u>, (A) to any person related to the undersigned
 by blood or adoption who is an immediate family member of the undersigned, or by marriage
 or domestic partnership (a "**Family Member** "), or to a trust formed for
 the benefit of the undersigned or any of the undersigned's Family Members, (B) to the
 undersigned's estate, following the death of the undersigned, by will, intestacy or
 other operation of law, (C) as a bona fide gift to a charitable organization, (D) by operation
 of law pursuant to a qualified domestic order or in connection with a divorce settlement
 or (E) to any partnership, corporation or limited liability company which is controlled by
 the undersigned and/or by any such Family Member(s);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii. if
 the undersigned is a <u>corporation, partnership or other business entity</u>, (A) to another
 corporation, partnership or other business entity that is an affiliate (as defined under
 Rule 12b-2 of the Exchange Act) of the undersigned, including investment funds or other entities
 under common control or management with the undersigned, (B) as a distribution or dividend
 to equity holders (including, without limitation, general or limited partners and members)
 of the undersigned (including upon the liquidation and dissolution of the undersigned pursuant
 to a plan of liquidation approved by the undersigned's equity holders) or (C) as a
 bona fide gift to a charitable organization; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iii. if
 the undersigned is a <u>trust</u>, to any grantors or beneficiaries of the trust;

 

*<u>provided that</u>*, in the case of any transfer or distribution pursuant to this clause (a), such transfer is not for value and each donee, heir, beneficiary or other transferee or distributee shall sign and deliver to My Size a lock-up agreement in the form of this Lock-Up Agreement with respect to the shares of My Size Common Stock or such other securities that have been so transferred or distributed;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) transfers
 or distributions pursuant to a bona fide third party tender offer, merger, consolidation
 or other similar transaction made to all holders of My Size Common Stock involving a change
 of control of My Size (including entering into any lock-up, voting or similar agreement pursuant
 to which the undersigned may agree to transfer, sell, tender or otherwise dispose of shares
 of My Size Common Stock (or any security convertible into or exercisable for My Size Common
 Stock), or vote any shares of My Size Common Stock in favor of any such transaction or taking
 any other action in connection with any such transaction) that has been approved by the Board
 of Directors of My Size, provided that the restrictions set forth in this Lock-Up Agreement
 shall continue to apply to the Undersigned's Shares should such tender offer, merger,
 consolidation or other transaction not be completed.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Any attempted transfer in violation of this Lock-Up Agreement will be of no effect and null and void, regardless of whether the purported transferee has any actual or constructive knowledge of the transfer restrictions set forth in this Lock-Up Agreement, and will not be recorded on the share register of My Size. In furtherance of the foregoing, the undersigned agrees that My Size and any duly appointed transfer agent for the registration or transfer of the securities described herein are hereby authorized to decline to make any transfer of securities if such transfer would constitute a violation or breach of this Lock-Up Agreement. In addition to any other legend, My Size may cause the legend set forth below, or a legend substantially equivalent thereto, to be placed upon any certificate(s) or other documents, ledgers or instruments evidencing the undersigned's ownership of My Size Common Stock:

THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO AND MAY ONLY BE TRANSFERRED IN COMPLIANCE WITH A LOCK-UP AGREEMENT, A COPY OF WHICH IS ON FILE AT THE PRINCIPAL OFFICE OF THE COMPANY.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The restrictions set forth in this Lock-Up Agreement shall be in addition to all other restrictions on transfer imposed by applicable United States and state securities laws, rules and regulations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The undersigned hereby represents and warrants that the undersigned has full power and authority to enter into this Lock-Up Agreement. All authority herein conferred or agreed to be conferred and any obligations of the undersigned shall be binding upon the successors, assigns, heirs or personal representatives of the undersigned.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. Any and all remedies herein expressly conferred upon My Size will be deemed cumulative with and not exclusive of any other remedy conferred hereby, or by law or equity, and the exercise by My Size of any one remedy will not preclude the exercise of any other remedy. The undersigned agrees that irreparable damage would occur to My Size in the event that any provision of this Lock-Up Agreement were not performed in accordance with its specific terms or were otherwise breached. It is accordingly agreed that My Size shall be entitled to an injunction or injunctions to prevent breaches of this Lock-Up Agreement and to enforce specifically the terms and provisions hereof in any court of the United States or any state having jurisdiction, this being in addition to any other remedy to which My Size is entitled at law or in equity, and the undersigned waives any bond, surety or other security that might be required of My Size with respect thereto.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. This Lock-Up Agreement and any claim, controversy or dispute arising under or related to this Lock-Up Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to the conflict of laws principles thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. This Lock-Up Agreement may be executed in several counterparts, each of which shall be deemed an original and all of which shall constitute one and the same instrument. The exchange of a fully executed Lock-Up Agreement (in counterparts or otherwise) by My Size and the undersigned by facsimile or electronic transmission in pdf format shall be sufficient to bind such parties to the terms and conditions of this Lock-Up Agreement.

(Signature Page Follows)

---

| | |
|:---|:---|
|  | Very truly yours, |
| **Print Name of Stockholder:** | /s/ Mr. Timo Steitz |
|  | **Signature:** |
|  | /s/ Mr. Wilhelm Steitz |
|  | **Signature:** |
|  | /s/ Mr. Ettore Weilenmann |
|  | **Signature:** |

---

[*Signature Page to Lock-up Agreement*]

---

| | |
|:---|:---|
| **Accepted and Agreed by** | **Accepted and Agreed by** |
| **MY SIZE INC.** | **MY SIZE INC.** |
| By: | /s/ Ronen Luzon |
| Name: | Mr. Ronen Luzon |
| Title: | Chief Executive Officer |

---

## Exhibit 10.3

**Exhibit 10.3**

**Certain confidential information contained in this document, marked by brackets and asterisk ([\*\*\*]), has been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K, because the Company customarily and actually treats such information as private or confidential and the omitted information is not material.**

**VOTING AGREEMENT**

This Voting Agreement ("<u>Voting Agreement</u>") is made as of September 8, 2025, by and among My Size, Inc., a company organized under the laws of the State of Delaware (the "<u>Company</u>"), and the parties identified on the signature page hereto (each a "<u>Stockholder</u>," and collectively, the "<u>Stockholders</u>").

WHEREAS, pursuant to that certain Share Sale Purchase Agreement, dated as of September 8, 2025 (the <u>"Purchase Agreement</u>"), by and among the Company and, inter alia, the Stockholders, the Stockholders have agreed to sell all of their Shares in ShoeSize.Me AG a corporation organized under the laws of Switzerland (the "<u>SZM Shares</u>"), to the Company in exchange for cash and shares of common stock, par value $0.001 per share, of the Company (the "<u>Company Common Stock</u>"), and the Company has agreed to purchase the SZM Shares from the Stockholders by paying cash and issuing shares of the Company Common Stock to the Stockholders, subject to the terms and conditions set forth in the Purchase Agreement (the shares of Company Common Stock to be issued to each Stockholder are defined herein as the "<u>Shares</u>");

WHEREAS, the closing of the transactions contemplated in the Purchase Agreement, including, without limitation, the issuance of the Shares by the Company to each Stockholder, is expressly conditioned on the Stockholders entering into of this Voting Agreement prior to such closing; and

WHEREAS, the Stockholders desire to enter into this Voting Agreement in order to induce the Company to close the transactions contemplated in the Purchase Agreement, including, without limitation, the issuance of the Shares to the Stockholders.

NOW, THEREFORE, in consideration of the foregoing premises and certain other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:

1. <u>Definitions</u>. All initial capitalized terms used but not otherwise defined herein shall have the meanings set forth in the Purchase Agreement.

2. <u>Shares Subject to Agreement</u>. The term "<u>Voting Shares</u>" as used in this Voting Agreement shall refer, individually and collectively, to (i) the Shares, and (ii) any other shares of the Company's capital stock owned (whether beneficially or as of record) by the Stockholders on or after the date hereof (the "<u>Additional Shares</u>"). The Stockholders hereby agree to hold any Voting Shares controlled or owned by them (whether beneficially or as of record), subject to the provisions of this Voting Agreement.

3. <u>Manner of Vote</u>. Any vote of the Voting Shares held by the Stockholders, whether at any meeting of the stockholders of the Company (including any adjournment(s), postponement(s) or continuation(s) thereof) or by written consent in lieu of a meeting of the stockholders of the Company, shall be exercised exclusively by such person (the "<u>Proxy</u>") designated from time to time by the Company's Board of Directors (the "<u>Board</u>") by written notice to the Stockholders; provided, that, if the voting power held by the Proxy, when taking into account the proxies granted by the Stockholders by this <u>Section 3</u> and <u>Section 4</u> of this Agreement and the Company Common Stock beneficially owned by the Proxy, represents 20% or more of the voting power of the Company's stockholders that will vote on an item, then the Proxy shall vote such number of Voting Shares in excess of 19.9% of the voting power of the existing stockholders of the Company on such item in the same proportion as shares of Company Common Stock are voted by the Company's other stockholders. The initial Proxy shall be Oren Elmaliah. Any vote of the Voting Shares by any person other than the then Proxy shall be invalid, and shall not count as a vote of Voting Shares for any purpose whatsoever.

4. <u>Irrevocable Proxy Coupled with an Interest.</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) In order to effect the foregoing voting arrangement, each Stockholder hereby irrevocably designates and appoints the then current Proxy as such Stockholder's sole and exclusive attorney-in-fact and proxy, with full power of substitution and re-substitution, for and in such Stockholder's name, to vote and exercise all voting rights (to the fullest extent such Stockholder is entitled to do so) with respect to the Voting Shares in the manner and to the effect determined by the Proxy, whether at any meeting of the stockholders of the Company (including any adjournment(s), postponement(s) or continuation(s) thereof) and in any other circumstances upon which the vote, consent (including a written consent in lieu of a meeting), or other approval of the stockholders of the Company is sought. The irrevocable proxy and power of attorney granted by each Stockholder pursuant to this <u>Section 4</u> shall terminate on the earliest to occur of (i) such time that such Stockholder no longer owns the Voting Shares, (ii) the sale of all or substantially all of the assets of the Company or the consolidation or merger of the Company with or into any other business entity pursuant to which stockholders of the Company prior to such consolidation or merger hold less than 50% of the voting equity of the surviving or resulting entity, (iii) the liquidation, dissolution or winding up of the business operations of the Company, and (iv) the filing or consent to filing of any bankruptcy, insolvency or reorganization case or proceeding involving the Company or otherwise seeking any relief under any laws relating to relief from debts or protection of debtors generally (the "<u>Expiration Date</u>").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The irrevocable proxy and power of attorney granted by each Stockholder pursuant to this <u>Section 4</u> is: (i) intended to be and shall be irrevocable to the full extent permitted by the Delaware General Corporation Law, (ii) coupled with an interest sufficient in law to support an irrevocable power, and (iii) granted in consideration of the Company issuing the Shares to the Stockholders, entering into this Voting Agreement and incurring certain related fees and expenses.

5. <u>Representations and Warranties of the Stockholders</u>. Each of the Stockholders represents, warrants and covenants to the Company as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Upon the issuance of the Shares to the Stockholder under the Purchase Agreement, the Stockholder shall be the sole legal and beneficial owner of such Shares which securities represent the only securities of the Company legally or beneficially owned by the Stockholder or that the Stockholder has voting power over. Except with respect to the Purchase Agreement, the Stockholder is not a party to any contract or agreement and owns no warrants, options or rights to purchase, subscribe for or otherwise acquire any securities of the Company. No person not a signatory to this Voting Agreement has a beneficial interest in or a right to acquire or vote any of the Voting Shares. Upon issuance, the Shares and any Additional Shares will be, free and clear of any lien, charge, claim, security interest, proxy, power of attorney, encumbrance, voting trust or agreement, understanding or arrangement of whatever nature that would adversely affect, or be inconsistent or interfere with, the Stockholder's ability to vote the Voting Shares in accordance with <u>Section 3</u> above or the Stockholder's ability to grant and the Proxy's ability to exercise the irrevocable proxy and power of attorney pursuant to <u>Section 4</u> above. The Stockholder has not granted, and prior to the Expiration Date will not grant, any other proxy or voting rights in respect of the Voting Shares to any other person.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The Stockholder has all requisite power, capacity and authority to enter into and perform this Voting Agreement. If this Voting Agreement is being executed in a representative or fiduciary capacity, the person signing this Voting Agreement has full power, capacity and authority to enter into and perform this Voting Agreement. This Voting Agreement has been duly executed and delivered by the Stockholder and constitutes a valid and binding obligation of the Stockholder, enforceable against the Stockholder in accordance with its terms, subject to applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and similar laws affecting creditors' rights and remedies generally, and to general principles of equity.

6. <u>Certain Covenants</u>. Except as provided in this Agreement, each Stockholder shall not, during the term of this Agreement, without the prior written consent of the Company, directly or indirectly: (i) grant any proxies or powers of attorney or enter into any voting trust or other agreement, understanding or arrangement of whatever nature with respect to the Voting Shares held by it that would adversely affect, or be inconsistent or interfere with its ability to vote the Voting Shares in accordance with <u>Section 3</u> above or its ability to grant and the Proxy's ability to exercise the irrevocable proxy and power of attorney pursuant to <u>Section 4</u> above; (ii) pledge, encumber or create a lien on, whether voluntarily or involuntarily or by operation of law, any Voting Shares; or (iii) take any other action that would adversely affect, or be inconsistent or interfere with the provsions of <u>Section 3</u> or <u>Section 4</u> above.

7. <u>Effective Date</u>; Term. This Voting Agreement shall remain in effect until the Expiration Date. Notwithstanding anything herein to the contrary, (i) this Voting Agreement shall not be effective or binding on the Stockholders until the closing of the transactions contemplated in the Purchase Agreement, whereupon all the terms and provisions hereof shall automatically become binding, and (ii) this Voting Agreement shall terminate immediately upon termination of the Purchase Agreement, for any reason, prior to closing thereunder.

8. <u>Successors in Interest</u>. The provisions of this Voting Agreement shall be binding upon the successors in interest to any of the Voting Shares. The Stockholders shall not transfer (whether voluntary or involuntary) any Voting Shares, or cause the Company or its transfer agent to record the transfer of the record ownership of any Voting Shares on its books (or issuing a new certificate representing any of the Voting Shares), unless and until the person to whom such Voting Shares are to be transferred shall have executed a written agreement pursuant to which such person becomes a party to this Voting Agreement and agrees to be bound by all the provisions hereof as if such person were an original signatory hereto.

9. <u>Legend</u>.<u> </u>In addition, to any other legend, each certificate representing any of the Voting Shares shall be marked with a legend reading as follows:

THE SHARES EVIDENCED HEREBY ARE SUBJECT TO A VOTING AGREEMENT (A COPY OF WHICH MAY BE OBTAINED FROM THE ISSUER) AND BY ACCEPTING ANY INTEREST IN SUCH SHARES THE PERSON HOLDING SUCH INTEREST SHALL BE DEEMED TO AGREE TO AND SHALL BECOME BOUND BY ALL THE PROVISIONS OF SAID VOTING AGREEMENT.

At any time after the termination of this Voting Agreement in accordance with <u>Section 7</u>, any holder of a stock certificate legended pursuant to this <u>Section 9</u> may surrender such certificate to the Company for removal of the legend.

10. <u>Specific Performance.</u> The parties hereto agree and the Stockholders expressly acknowledge that the Company may be irreparably damaged if for any reason the Stockholders fail to perform any of their obligations under this Voting Agreement, and that the Company may not have any adequate remedy at law for money damages in such event. Accordingly the Stockholders agree that in the case of the failure of the Stockholders to perform the Company shall be entitled to specific performance and injunctive and other equitable relief to enforce the performance of this Voting Agreement by the Stockholders, and further agree that any such specific performance and injunctive and/or other equitable relief, in addition to remedies at law or damages, is the appropriate remedy for any such failure to perform, and further agree that the Stockholders will not seek, and agree to waive any requirement for, the securing or posting of a bond in connection with the Company's seeking or obtaining such equitable relief. This provision is without prejudice to any other rights that the Company may have against the Stockholders for any failure to perform its obligations under this Voting Agreement.

11. <u>Remedies</u>. All remedies, either under this Voting Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.

12. <u>Miscellaneous</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.1 <u>Governing Law</u>. All questions concerning the construction, validity, enforcement and interpretation of this Voting Agreement shall be governed by the internal laws of the State of Delaware, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Delaware or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of Delaware. Each party hereby irrevocably submits to the exclusive jurisdiction of the state courts of the State of Delaware, for the adjudication of any dispute hereunder, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this Voting Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS VOTING AGREEMENT. If any party shall commence an action or proceeding to enforce any provisions of the Voting Agreement, then the prevailing party in such action or proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys' fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.2 <u>Successors and Assigns</u>. Except as otherwise provided herein, the provisions hereof shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors, and administrators of the parties hereto. Nothing in this Voting Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective permitted successors and assigns any rights, remedies, obligations or liabilities under or by reason of this Voting Agreement, except as expressly provided by this Voting Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.3 <u>Entire Agreement</u>. This Voting Agreement, together with any exhibits and schedules thereto, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.4 <u>Notices, Etc</u>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via facsimile at the facsimile number or email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a business day, (b) the next business day after the time of transmission, if such notice or communication is delivered via facsimile at the facsimile number or email attachment at the email address as set forth on the signature pages attached hereto on a day that is not a business day or later than 5:30 p.m. (New York City time) on any business day, (c) the second (2nd) business day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.5 <u>Delays or Omissions</u>. No delay or omission to exercise any right, power, or remedy accruing to any party upon any breach or default of another party under this Voting Agreement shall impair any such right, power, or remedy of such party, nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent, or approval of any kind or character on the part of any party of any breach or default under this Voting Agreement, or any waiver on the part of any party of any provisions or conditions of this Voting Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing or as provided in this Voting Agreement. All remedies, either under this Voting Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.6 <u>Counterparts</u>. This Voting Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a ".pdf" format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or ".pdf" signature page were an original thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.7 <u>Severability</u>. If any term, provision, covenant or restriction of this Voting Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.8 <u>Headings</u>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.9 <u>Amendment and Waiver</u>. Any provision of this Voting Agreement may be amended or waived (either generally or in a particular instance and either retroactively or prospectively) only by an agreement in writing of the party against whom enforcement is sought.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.10 <u>Stock Splits, Stock Dividends, etc</u>.. In the event of any stock split, stock dividend, merger, reorganization, recapitalization or other change in the capital structure of the Company or the acquisition of additional shares of the Company Common Stock or other voting securities of the Company by the Stockholders after the date of this Voting Agreement, the number of Voting Shares subject to the terms of this Voting Agreement shall be adjusted automatically, as appropriate, and all such Voting Shares shall be automatically subject to this Voting Agreement and endorsed with the legend set forth in <u>Section 9</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.11 <u>Representation by Counsel</u>. Each Stockholder acknowledges that it has been represented by counsel or had the full opportunity to represented by counsel in, the drafting of the Voting Agreement. If a Stockholder has not taken the opportunity available to it to be represented by counsel in this transaction, it has done so with full awareness of the risks of not engaging counsel, has had the opportunity to confer with counsel as to what such risks are, and has knowingly assumed any and all such risks. Any applicable rule of construction to the effect that ambiguities are to be resolved against the drafting party will not be applied in connection with the construction or interpretation of the Voting Agreement.

[Signature Page Follows]

IN WITNESS WHEREOF, the parties have executed this Voting Agreement as of the date first above written.

---

| | |
|:---|:---|
| My Size, Inc. | My Size, Inc. |
| By: | /s/ Ronen Luzon |
| Name: | Ronen Luzon |
| Title: | Chief Executive Officer |
| Address for Notice: [\*\*\*] | Address for Notice: [\*\*\*] |
| E-mail: | [\*\*\*] |

---

---

| |
|:---|
| /s/ Timo Steitz |
| Timo Steitz |
| Address for Notice: [\*\*\*] |
| E-mail:[\*\*\*] |
| /s/ Wilhelm Steitz |
| Wilhelm Steitz |
| Address for Notice: [\*\*\*] |
| E-mail: [\*\*\*] |
| /s/ Ettore Weilenmann |
| Ettore Weilenmann |
| Address for Notice: [\*\*\*] |
| Email: [\*\*\*] |

---

## Exhibit 10.4

**Exhibit 10.4**

NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION (the "COMMISSION") OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

**COMMON STOCK PURCHASE WARRANT**

**MY SIZE, INC.**

Warrant Shares: 28,000 Issue Date: September 8, 2025

COMMON STOCK PURCHASE WARRANT (the "<u>Warrant</u>") certifies that, for value received, Mr. Sebastian Gacond or its assignees (the "<u>Holder</u>") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date (subject to the vesting provisions of Section 1 herein) and on or prior to 5:00 p.m. (New York City time) on September 7, 2030 (the "<u>Termination Date</u>") but not thereafter, to subscribe for and purchase from My Size, Inc., a Delaware corporation (the "<u>Company</u>"), up to 28,000 shares (as subject to adjustment hereunder, the "<u>Warrant Shares</u>") of the Company's common stock, par value $0.001 per share, and any other class of securities into which such securities may hereafter be reclassified or changed (the "<u>Common Stock</u>"). The purchase price of one share of Common Stock under this Warrant shall be equal to the Applicable Exercise Price, as defined in Section 2(b).

<u>Section 1</u>. <u>Vesting.</u> The Warrant Shares shall vest and become exercisable in accordance with the following schedule:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) 50%
 of the Warrant Shares shall vest and become exercisable on the 12-month anniversary of the
 Issue Date (the "Initial Exercise Date"), provided, that the Holder shall have
 been continuously providing services to **ShoeSize.Me AG**, a corporation (Aktiengesellschaft)
 duly constituted under the laws of Switzerland, with registered office at [\*\*\*], and registered
 within the Commercial Register of the canton of Solothurn under number [\*\*\*] ("SZM")
 or any subsidiary of SZM through such date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Up
 to 25% of the Warrant Shares shall vest and become exercisable as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. if
 the Gross Revenue of SZM, during the period commencing on September 1, 2025 and ending on
 August 31, 2026 shall be equal to or greater than 80% but lower than 95% of Gross Revenue
 of SZM, during the period commencing on September 1, 2024 and ending on August 31, 2025,
 then 12.5% of the Warrant Shares shall vest and become exercisable; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. alternatively,
 if the Gross Revenue of SZM, during the period commencing on September 1, 2025 and ending
 on August 31, 2026 shall be equal to or greater than 95% of the Gross Revenue of SZM, during
 the period commencing on September 1, 2024 and ending on August 31, 2025, then 25% of the
 Warrant Shares shall vest and become exercisable. For purposes hereof, the term "Gross
 Revenue" shall mean the gross revenue determined and calculated based on the books
 and records of SZM and in accordance with SZM's the revenue recognition rules and practices
 during the last three (3) years preceding August 31, 2025.

For the avoidance of doubt, in no event shall the number of Warrant Shares issuable under this Warrant pursuant to Section 1b)b. exceed the number of Warrant Shares issuable pursuant to Section 1b)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) 25%
 of the Warrant Shares shall vest and become exercisable, upon completion of the full integration
 (as determined by the Company at its reasonable discretion) of the Subsidiary into NAIZ BESPOKE
 TECHNOLOGIES, S.L., a wholly-owned subsidiary of the Company; provided, however, that such
 Warrant Shares shall vest and become exercisable only if such integration is completed at
 or prior to March 31, 2026.

<u>Section 2</u>. <u>Exercise</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) <u>Exercise of Warrant</u>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the "<u>Notice of Exercise</u>"). Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(c)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier's check drawn on a United States bank. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Trading Day of receipt of such notice. **The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Exercise Price. The exercise price per share of each Warrant Shares (the "<u>Applicable Exercise Price</u>") shall be equal to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. with
 respect to 10,000 of the Warrant Shares, $2.00;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii. with
 respect to 6,000 of the Warrant Shares, $3.00;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iii. with
 respect to 5,000 of the Warrant Shares $4.00;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iv. with
 respect to 4,000 of the Warrant Shares $5.00; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;v. with
 respect to 3,000 of the Warrant Shares $6.00;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) <u>Mechanics of Exercise</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. <u>Delivery of Warrant Shares Upon Exercise</u>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent (herein defined) to the Holder by crediting the account of the Holder's or its designee's balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system ("<u>DWAC</u>") if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in the Company's share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the "<u>Warrant Share Delivery Date</u>"). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received by the Warrant Share Delivery Date. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable (the "Transfer Agent"). As used herein, "<u>Standard Settlement Period</u>" means the standard settlement period, expressed in a number of Trading Days, on the Company's primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii. <u>Delivery of New Warrants Upon Exercise</u>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant; provided, however, that the Holder shall be required to return any Warrant Shares subject to any such rescinded exercise notice concurrently with the return to Holder of the aggregate Exercise Price paid to the Company for such Warrant Shares and the restoration of Holder's right to acquire such Warrant Shares pursuant to this Warrant (including, issuance of a replacement warrant certificate evidencing such restored right).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iii. <u>No Fractional Shares or Scrip</u>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Applicable Exercise Price or round up to the next whole share.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iv. <u>Charges, Taxes and Expenses</u>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <u>provided</u>, <u>however</u>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;v. <u>Closing of Books</u>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) <u>Holder's Exercise Limitations</u>. The Company shall not affect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder's Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder's Affiliates (such Persons, "<u>Attribution Parties</u>")), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(d), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(d) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder's determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(d), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company's most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The "<u>Beneficial Ownership Limitation</u>" shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(d), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(d) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<sup>st</sup> day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(d) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant. For purposes hereof, the term "Affiliate" means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act. For purposes hereof, "<u>Exchange Act</u>" means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder and "<u>Securities Act</u>" means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

<u>Section 3</u>. <u>Certain Adjustments</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) <u>Stock Dividends and Splits</u>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Applicable Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Applicable Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) <u>Subsequent Rights Offerings</u>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the "<u>Purchase Rights</u>"), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<u>provided</u>, <u>however</u>, that to the extent that the Holder's right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation). "<u>Common Stock Equivalents</u>" means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) <u>Pro Rata Distributions</u>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend (other than cash) or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a "<u>Distribution</u>"), at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<u>provided</u>, <u>however</u>, that to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) <u>Fundamental Transaction</u>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock or 50% or more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock or 50% or more of the voting power of the common equity of the Company (each a "<u>Fundamental Transaction</u>"), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(d) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the "<u>Alternate Consideration</u>") receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(d) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Applicable Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Applicable Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the "<u>Successor Entity</u>") to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term "Company" under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the "Company" shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company herein. For purposes hereof, "<u>Business Day</u>" means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by law to remain closed; <u>provided</u>, <u>however</u>, for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to "stay at home", "shelter-in-place", "non-essential employee" or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally open for use by customers on such day. For purposes hereof, "<u>Person</u>" means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e) <u>Calculations</u>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f) <u>Notice to Holder</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. <u>Adjustment to Exercise Price</u>. Whenever the Applicable Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by email a notice setting forth the Applicable Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii. <u>Notice to Allow Exercise by Holder</u>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

<u>Section 4</u>. <u>Transfer of Warrant</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) <u>Transferability</u>. Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) <u>New Warrants</u>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) <u>Warrant Register</u>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the "<u>Warrant Register</u>"), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) <u>Transfer Restrictions</u>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant, as the case may be, comply with the provisions of Section 5(j) herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e) <u>Representation by the Holder</u>. The Holder, by the acceptance hereof, represents, warrants and acknowledges that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. the
 Holder is acquiring this Warrant and, upon any exercise hereof, will acquire the Warrant
 Shares issuable upon such exercise, for its own account and not with a view to or for distributing
 or reselling such Warrant Shares or any part thereof in violation of the Securities Act or
 any applicable state securities law, except pursuant to sales registered or exempted under
 the Securities Act;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii. (i)
 the issuance of the Warrant and/or the Warrant Shares have not been reviewed by the Commission
 nor any state regulatory authority since the issuance of the Warrant and/or the Warrant Shares
 is intended to be exempt from the registration requirements of Section 4(a)(2) of the Securities
 Act and Rule 506 of Regulation D, (ii) the Holder understands that the Warrant and/or the
 Warrant Shares have not been registered under the Securities Act or under any state securities
 or "blue sky" laws, (iii) the Holder understands that the Warrant and/or the
 Warrant Shares have not been registered under the Securities Act by reason of a claimed exemption
 under the provisions of the Securities Act that depends, in part, upon Holder's investment
 intention and in this connection hereby represents that it is acquiring the Warrant and/or
 the Warrant Shares for its own account for investment and not with a view toward the resale
 or distribution to others, (iv) the Holder was not formed for the purpose of purchasing the
 Warrant and/or the Warrant Shares, (v) the Holder consents to the placement of a legend on
 any certificate or other document evidencing the Warrant and/or the Warrant Shares have not
 been registered under the Securities Act or any state securities or "blue sky"
 laws, (vi) the Holder is acquiring the Warrant and/or the Warrant Shares solely for its own
 account for investment and not with a view to, or for resale in connection with, any distribution,
 (vii) if the Holder is a U.S. Person (as defined in Rule 902 under the Securities Act), such
 Holder is an "accredited investor" as such term is defined in Rule 501(a) of
 Regulation D promulgated under the Securities Act, and (viii) the Holder is aware that the
 Company is under no obligation to effect any such registration or to file for or comply with
 any exemption from registration. The Holder further understands and agrees that it shall
 be solely responsible for and shall bear all tax and/or other mandatory payment and/or consequences
 arising from the grant of the Warrant and the Warrant Shares and that the Company may withhold
 the amount of the tax and/or other mandatory payment of which is required with respect to
 the Warrant and the Warrant Shares under any applicable law, in accordance with the tax withholdings
 approval provided by the Holder from time to time, if provided and applicable law. In the
 event that the Company determines that it is required to withhold any tax as a result of
 the grant or issuance of the Warrant and/or the Warrant Shares, as a condition to the grant
 or issuance of the Warrant and the Shares, the Holder shall make arrangements satisfactory
 to the Company to enable it to satisfy all withholding requirements.

<u>Section 5</u>. <u>Miscellaneous</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) <u>No Rights as Stockholder Until Exercise; No Settlement in Cash</u>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d), except as expressly set forth in Section 3. In no event will the Company be required to net cash settle an exercise of this Warrant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) <u>Loss, Theft, Destruction or Mutilation of Warrant</u>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) <u>Saturdays, Sundays, Holidays, etc</u>. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading Day.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) <u>Authorized Shares</u>.

Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.

Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Applicable Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e) <u>Restrictions</u>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f) <u>Nonwaiver and Expenses</u>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder's rights, powers or remedies, notwithstanding the fact that the right to exercise this Warrant terminates on the Termination Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g) <u>Notices</u>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered to the address for the Holder that appears in the Company's Warrant Register.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;h) <u>Limitation of Liability</u>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i) <u>Remedies</u>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;j) <u>Successors and Assigns</u>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;k) <u>Amendment</u>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;l) <u>Severability</u>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;m) <u>Headings</u>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;n) <u>Governing Law; Jurisdiction</u>. All questions concerning the construction, validity, enforcement and interpretation of the Warrant shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof and all legal proceedings concerning the interpretations and enforcement of this Warrant shall be commenced exclusively in the state and federal courts sitting in the City of New York.

\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*

 

*(Signature Page Follows)*

 

IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

---

| |
|:---|
| **MY SIZE, INC.** |
| By: |
| Name: |
| Title:<br>|

---

**NOTICE OF EXERCISE**

---

| | |
|:---|:---|
| To: | **MY SIZE, INC.** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

The Warrant Shares shall be delivered to the following DWAC Account Number:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) <u>Accredited Investor</u>. The undersigned is an "accredited investor" as defined in Regulation D promulgated under the Securities Act of 1933, as amended.

[SIGNATURE OF HOLDER]

Name of Investing Entity: ________________________________________________________________________

*Signature of Authorized Signatory of Investing Entity*: _________________________________________________

Name of Authorized Signatory: ___________________________________________________________________

Title of Authorized Signatory: ____________________________________________________________________

Date: ________________________________________________________________________________________

**EXHIBIT B**

ASSIGNMENT FORM

*(To assign the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)*

 

FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to

---

| | |
|:---|:---|
| Name: | |
|  | (Please Print) |
| Address: | |
|  | (Please Print) |
| Phone Number: | |
| Email Address: | |
| Dated: _______________ __, ______ |  |
| Holder's Signature: ___________________________ |  |
| Holder's Address: ____________________________ |  |

---

## Exhibit 99.1

**Exhibit 99.1**

**MySize Inc. Expands Naiz Fit Platform with Acquisition of ShoeSize.Me, Adding AI-Powered Footwear Sizing to Its Fashion Tech Roll-Up Strategy**

Strategic Move Bolsters MySize's B2B & Tech Portfolio and Aligns with Retail Data Generation strategy

**Airport City, Israel – September 11, 2025 –** MySize, Inc. (NASDAQ: MYSZ) ("MySize" or the "Company"), a leading AI-driven measurement and fashion technology solutions provider, today announced the acquisition of **ShoeSize.Me**, a European SaaS company specializing in AI-powered footwear sizing and fit solutions. The transaction, structured primarily as a share deal, underscores MySize's commitment to protecting its cash position while executing its strategic **roll-up plan** led by CEO **Ronen Luzon**.

ShoeSize.Me serves **20+ fashion retailers**, with a strong footprint in **Central Europe** and key clients including **Alshaya Group** (Foot Locker partner in the Middle East). The company is on track to surpass **€0.5 million in SaaS revenues in 2025** through its **ShoeAI solution**, which delivers highly accurate footwear sizing recommendations.

With this acquisition, ShoeSize.Me will operate under the **Naiz Fit umbrella**, creating the first unified platform that solves sizing and fit challenges across both **apparel and footwear**. This integration is expected to also enhance **cross-selling opportunities** across the combined customer base, unlocking revenue synergies in Europe, the Middle East, and beyond.

*"This acquisition marks another milestone in our consolidation strategy,"* said **Ronen Luzon, CEO of MySize**. *"By bringing together Naiz Fit's leadership in apparel and ShoeSize.Me's cutting-edge footwear solution, we are building the most comprehensive sizing platform in the market. This not only expands our geographic reach but strengthens our cross-selling potential and our position as a consolidator in fashion tech."*

 

Beyond commercial expansion, ShoeSize.Me strengthens MySize's **data strategy**. The company's technology has already analyzed more than **92 million consumer shopping experiences, 23 million shoe sizes on 19 international scales, 1.2 million shoe models and more than 6.000 brands** across footwear categories, adding critical depth to Naiz Fit's growing data lake. This enriched data set is expected to accelerate product innovation, improve accuracy, and generate new insights for retail partners.

*"Joining MySize and Naiz Fit gives us the scale and platform to accelerate ShoeAI adoption globally,"* said Timo Steitz Founder of ShoeSize.Me. *"Together, we are redefining how consumers find the right fit—whether in clothes or shoes—while helping retailers reduce returns, improve margins, and build customer loyalty."*

 

 

This acquisition follows MySize's strategy to **identify and acquire synergistic businesses** that strengthen its SaaS portfolio and data assets. With apparel, footwear, and big data now under one platform, MySize continues to position itself as the **go-to technology consolidator** for solving fashion e-commerce's sizing challenge.

Pursuant to the terms of the acquisition, MySize issued an aggregate of 241,093 shares of common stock to the sellers of ShoeSize.Me plus a cash payment of an aggregate of $150,000. In addition, in connection with the acquisition, MySize issued a five-year milestone vesting warrant to purchase 28,000 shares of common stock to a key employee of ShoeSize.Me.

**About My Size, Inc.**

MySize, Inc. (NASDAQ: MYSZ) is a global leader in omnichannel e-commerce platforms and AI-driven retail solutions, including MySizeID and Naiz Fit. The Company's solutions are designed to drive revenue growth, reduce operational costs, and enhance customer experiences for business clients worldwide.

We routinely post information that may be important to investors in the Investor Relations section of our website. Follow us on Facebook, LinkedIn, Instagram, and X (formerly known as Twitter).

For more information, visit www.mysizeid.com.

**Cautionary Statement Regarding Forward-Looking Statements**

This press release contains certain forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements related to the acquisition, expected revenues, anticipated benefits and impact of the acquisition of ShoeSize.Me on MySize and the anticipated market opportunity. These statements are identified by the use of the words "could," "believe," "anticipate," "intend," "estimate," "expect," "may," "continue," "predict," "potential," "project" and similar expressions that are intended to identify forward-looking statements. All forward-looking statements speak only as of the date of this press release. You should not place undue reliance on these forward-looking statements. Although we believe that our plans, objectives, expectations and intentions reflected in or suggested by the forward-looking statements are reasonable, we can give no assurance that these plans, objectives, expectations or intentions will be achieved. Forward-looking statements involve significant risks and uncertainties (some of which are beyond our control) and assumptions that could cause actual results to differ materially from historical experience and present expectations or projections. Actual results may differ materially from those in the forward-looking statements and the trading price for our common stock may fluctuate significantly. Forward-looking statements also are affected by the risk factors described in the Company's filings with the U.S. Securities and Exchange Commission. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

Investor Contacts:

Oren Elmaliah, CFO

ir@mysizeid.com